,pathway_count
IMMUNE SYSTEM,132
SIGNAL TRANSDUCTION,111
CYTOKINE SIGNALING IN IMMUNE SYSTEM,98
SIGNALING BY INTERLEUKINS,76
DISEASE,74
INNATE IMMUNE SYSTEM,63
GENERIC TRANSCRIPTION PATHWAY,54
RNA POLYMERASE II TRANSCRIPTION,54
GENE EXPRESSION (TRANSCRIPTION),54
METABOLISM OF PROTEINS,53
PI3K-AKT SIGNALING PATHWAY,41
DISEASES OF SIGNAL TRANSDUCTION,38
ADAPTIVE IMMUNE SYSTEM,37
HEMOSTASIS,37
DEVELOPMENTAL BIOLOGY,37
SIGNALING BY RECEPTOR TYROSINE KINASES,37
POST-TRANSLATIONAL PROTEIN MODIFICATION,36
INTERLEUKIN-4 AND INTERLEUKIN-13 SIGNALING,36
INFECTIOUS DISEASE,33
REGULATION OF TOLL-LIKE RECEPTOR SIGNALING PATHWAY,32
JAK-STAT,32
VEGFA-VEGFR2 SIGNALING PATHWAY,32
SIGNALING BY GPCR,31
CELLULAR RESPONSES TO STRESS,30
CELLULAR RESPONSES TO EXTERNAL STIMULI,30
INTRACELLULAR SIGNALING BY SECOND MESSENGERS,30
PIP3 ACTIVATES AKT SIGNALING,29
GPCR DOWNSTREAM SIGNALLING,28
FOCAL ADHESION-PI3K-AKT-MTOR-SIGNALING PATHWAY,28
TOLL-LIKE RECEPTOR SIGNALING PATHWAY,28
APOPTOSIS,27
NEUTROPHIL DEGRANULATION,27
SPINAL CORD INJURY,27
"PLATELET ACTIVATION, SIGNALING AND AGGREGATION",26
BREAST CANCER PATHWAY,24
TOLL-LIKE RECEPTOR CASCADES,24
SENESCENCE AND AUTOPHAGY IN CANCER,24
METABOLISM,24
VIRAL ACUTE MYOCARDITIS,23
ADIPOGENESIS,23
PANCREATIC ADENOCARCINOMA PATHWAY,23
MAPK SIGNALING PATHWAY,23
T-CELL ANTIGEN RECEPTOR (TCR) SIGNALING PATHWAY,22
NUCLEAR RECEPTORS META-PATHWAY,22
MAPK FAMILY SIGNALING CASCADES,22
LEPTIN SIGNALING PATHWAY,22
PROLACTIN SIGNALING PATHWAY,22
BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) SIGNALING PATHWAY,22
DNA DAMAGE RESPONSE (ONLY ATM DEPENDENT),22
GPCR LIGAND BINDING,22
ALLOGRAFT REJECTION,22
TOLL LIKE RECEPTOR 4 (TLR4) CASCADE,21
CLASS A/1 (RHODOPSIN-LIKE RECEPTORS),21
PI3K/AKT SIGNALING IN CANCER,21
R-HSA-9675108,20
NEGATIVE REGULATION OF THE PI3K/AKT NETWORK,20
G ALPHA (I) SIGNALLING EVENTS,20
AXON GUIDANCE,20
MAPK1/MAPK3 SIGNALING,20
FLT3 SIGNALING,20
ONCOSTATIN M SIGNALING PATHWAY,20
INTERLEUKIN-10 SIGNALING,20
NONALCOHOLIC FATTY LIVER DISEASE,20
INTERFERON SIGNALING,20
T-CELL ANTIGEN RECEPTOR (TCR) PATHWAY DURING STAPHYLOCOCCUS AUREUS INFECTION,19
ANDROGEN RECEPTOR SIGNALING PATHWAY,19
"PI5P, PP2A AND IER3 REGULATE PI3K/AKT SIGNALING",19
FOCAL ADHESION,19
CHEMOKINE SIGNALING PATHWAY,19
PEPTIDE LIGAND-BINDING RECEPTORS,19
TRANSCRIPTIONAL REGULATION BY TP53,19
HEPATITIS C AND HEPATOCELLULAR CARCINOMA,19
SUDDEN INFANT DEATH SYNDROME (SIDS) SUSCEPTIBILITY PATHWAYS,19
FOLATE METABOLISM,18
DEUBIQUITINATION,18
RAF/MAP KINASE CASCADE,18
ESR-MEDIATED SIGNALING,18
SIGNALING BY NUCLEAR RECEPTORS,18
THYMIC STROMAL LYMPHOPOIETIN (TSLP) SIGNALING PATHWAY,18
B CELL RECEPTOR SIGNALING PATHWAY,18
AGE-RAGE PATHWAY,18
KIT RECEPTOR SIGNALING PATHWAY,18
RAC1-PAK1-P38-MMP2 PATHWAY,18
EGF-EGFR SIGNALING PATHWAY,18
IL-2 SIGNALING PATHWAY,18
LUNG FIBROSIS,18
CELL CYCLE,17
ENDOMETRIAL CANCER,17
PROGRAMMED CELL DEATH,17
MICRORNAS IN CARDIOMYOCYTE HYPERTROPHY,17
SIGNALING PATHWAYS IN GLIOBLASTOMA,17
IL-3 SIGNALING PATHWAY,17
TGF-BETA SIGNALING PATHWAY,17
EBOLA VIRUS PATHWAY ON HOST,17
ERBB SIGNALING PATHWAY,17
EXTRACELLULAR MATRIX ORGANIZATION,17
PHOTODYNAMIC THERAPY-INDUCED AP-1 SURVIVAL SIGNALING.,17
SELENIUM MICRONUTRIENT NETWORK,16
VESICLE-MEDIATED TRANSPORT,16
CHROMOSOMAL AND MICROSATELLITE INSTABILITY IN COLORECTAL CANCER,16
MYD88:MAL(TIRAP) CASCADE INITIATED ON PLASMA MEMBRANE,16
MYD88-INDEPENDENT TLR4 CASCADE ,16
TOLL LIKE RECEPTOR TLR1:TLR2 CASCADE,16
TOLL LIKE RECEPTOR TLR6:TLR2 CASCADE,16
TOLL LIKE RECEPTOR 2 (TLR2) CASCADE,16
TRIF(TICAM1)-MEDIATED TLR4 SIGNALING ,16
IL-4 SIGNALING PATHWAY,16
FIBRIN COMPLEMENT RECEPTOR 3 SIGNALING PATHWAY,16
PHOTODYNAMIC THERAPY-INDUCED NF-KB SURVIVAL SIGNALING,16
MIRNAS INVOLVEMENT IN THE IMMUNE RESPONSE IN SEPSIS,16
INTERLEUKIN-1 FAMILY SIGNALING,16
VITAMIN B12 METABOLISM,15
NON-SMALL CELL LUNG CANCER,15
R-HSA-9658195,15
SIGNALING BY NTRKS,15
TOLL LIKE RECEPTOR 9 (TLR9) CASCADE,15
TOLL LIKE RECEPTOR 7/8 (TLR7/8) CASCADE,15
CELLULAR SENESCENCE,15
EXTRA-NUCLEAR ESTROGEN SIGNALING,15
TRAF6 MEDIATED INDUCTION OF NFKB AND MAP KINASES UPON TLR7/8 OR 9 ACTIVATION,15
MYD88 DEPENDENT CASCADE INITIATED ON ENDOSOME,15
RANKL-RANK (RECEPTOR ACTIVATOR OF NFKB (LIGAND)) SIGNALING PATHWAY,15
CORTICOTROPIN-RELEASING HORMONE SIGNALING PATHWAY,15
EPITHELIAL TO MESENCHYMAL TRANSITION IN COLORECTAL CANCER,15
INSULIN SIGNALING,15
"INTERLEUKIN-3, INTERLEUKIN-5 AND GM-CSF SIGNALING",15
CONSTITUTIVE SIGNALING BY ABERRANT PI3K IN CANCER,15
VITAMIN D RECEPTOR PATHWAY,15
MEMBRANE TRAFFICKING,14
CYTOKINES AND INFLAMMATORY RESPONSE,14
PLATELET DEGRANULATION ,14
RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2+,14
TOLL LIKE RECEPTOR 3 (TLR3) CASCADE,14
HUMAN THYROID STIMULATING HORMONE (TSH) SIGNALING PATHWAY,14
BLADDER CANCER,14
RAS SIGNALING,14
"NON-GENOMIC ACTIONS OF 1,25 DIHYDROXYVITAMIN D3",14
TRANSCRIPTIONAL REGULATION BY RUNX1,14
INTERFERON GAMMA SIGNALING,14
INTERFERON TYPE I SIGNALING PATHWAYS,14
SIGNALING BY NOTCH,14
IL-6 SIGNALING PATHWAY,13
MIRNA REGULATION OF DNA DAMAGE RESPONSE,13
DNA DAMAGE RESPONSE,13
IL-5 SIGNALING PATHWAY,13
TNF RELATED WEAK INDUCER OF APOPTOSIS (TWEAK) SIGNALING PATHWAY,13
INTERLEUKIN-11 SIGNALING PATHWAY,13
PROTEIN ALKYLATION LEADING TO LIVER FIBROSIS,13
MIRNA REGULATION OF PROSTATE CANCER SIGNALING PATHWAYS,13
INTERLEUKIN-2 FAMILY SIGNALING,13
MIR-TARGETED GENES IN LYMPHOCYTES - TARBASE,13
DEATH RECEPTOR SIGNALLING,13
SUMOYLATION,13
SUMO E3 LIGASES SUMOYLATE TARGET PROTEINS,13
SIGNALING BY PTK6,13
SIGNALING BY NON-RECEPTOR TYROSINE KINASES,13
UB-SPECIFIC PROCESSING PROTEASES,12
COSTIMULATION BY THE CD28 FAMILY,12
TOLL LIKE RECEPTOR 10 (TLR10) CASCADE,12
TOLL LIKE RECEPTOR 5 (TLR5) CASCADE,12
SIGNALING BY NTRK1 (TRKA),12
MYD88 CASCADE INITIATED ON PLASMA MEMBRANE,12
IL-1 SIGNALING PATHWAY,12
ANDROGEN RECEPTOR NETWORK IN PROSTATE CANCER,12
ARYL HYDROCARBON RECEPTOR,12
ESC PLURIPOTENCY PATHWAYS,12
MIR-TARGETED GENES IN MUSCLE CELL - TARBASE,12
SIGNALING BY VEGF,12
VEGFA-VEGFR2 PATHWAY,12
TRANSCRIPTIONAL REGULATION BY RUNX3,12
DIFFERENTIATION PATHWAY,12
CELL SURFACE INTERACTIONS AT THE VASCULAR WALL,12
SIGNALING BY SCF-KIT,12
METABOLISM OF LIPIDS,12
HUMAN COMPLEMENT SYSTEM,11
CLATHRIN-MEDIATED ENDOCYTOSIS,11
FC EPSILON RECEPTOR (FCERI) SIGNALING,11
"CELL CYCLE, MITOTIC",11
INTEGRATED BREAST CANCER PATHWAY,11
ANGIOGENESIS OVERVIEW,11
TNF ALPHA SIGNALING PATHWAY,11
CARDIAC HYPERTROPHIC RESPONSE,11
ASSOCIATION BETWEEN PHYSICO-CHEMICAL FEATURES AND TOXICITY ASSOCIATED PATHWAYS,11
MET IN TYPE 1 PAPILLARY RENAL CELL CARCINOMA,11
LTF DANGER SIGNAL RESPONSE PATHWAY,11
TGF-BETA RECEPTOR SIGNALING,11
HEMATOPOIETIC STEM CELL DIFFERENTIATION,11
CHEMOKINE RECEPTORS BIND CHEMOKINES,11
RIG-I-LIKE RECEPTOR SIGNALING,11
REGULATION OF TP53 ACTIVITY,11
INTERFERON ALPHA/BETA SIGNALING,11
APOPTOSIS MODULATION AND SIGNALING,11
PATHWAYS IN CLEAR CELL RENAL CELL CARCINOMA,11
SIGNALING BY RHO GTPASES,10
CARGO RECOGNITION FOR CLATHRIN-MEDIATED ENDOCYTOSIS,10
TCR SIGNALING,10
CELLULAR RESPONSE TO HEAT STRESS,10
FOXO-MEDIATED TRANSCRIPTION,10
SENESCENCE-ASSOCIATED SECRETORY PHENOTYPE (SASP),10
TRANSCRIPTIONAL REGULATION BY RUNX2,10
IL-7 SIGNALING PATHWAY,10
APOPTOSIS-RELATED NETWORK DUE TO ALTERED NOTCH3 IN OVARIAN CANCER,10
ANGIOPOIETIN LIKE PROTEIN 8 REGULATORY PATHWAY,10
RESISTIN AS A REGULATOR OF INFLAMMATION,10
REGULATION OF ACTIN CYTOSKELETON,10
SIGNALING BY PDGF,10
IL1 AND MEGAKARYOCYTES IN OBESITY,10
NOTCH SIGNALING PATHWAY,10
EXTRACELLULAR VESICLES IN THE CROSSTALK OF CARDIAC CELLS,10
CLASS I MHC MEDIATED ANTIGEN PROCESSING & PRESENTATION,10
PEPTIDE HORMONE METABOLISM,9
RHO GTPASE EFFECTORS,9
TRANSPORT OF SMALL MOLECULES,9
DOWNSTREAM TCR SIGNALING,9
PTEN REGULATION,9
WNT SIGNALING PATHWAY,9
TOLL-LIKE RECEPTOR SIGNALING,9
ESTROGEN SIGNALING PATHWAY,9
ENDOCHONDRAL OSSIFICATION,9
CONTROL OF IMMUNE TOLERANCE BY VASOACTIVE INTESTINALPEPTIDE,9
MIR-TARGETED GENES IN EPITHELIUM - TARBASE,9
TYPE II INTERFERON SIGNALING (IFNG),9
CARDIAC PROGENITOR DIFFERENTIATION,9
IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON-LYMPHOID CELL,9
REGULATION OF INSULIN-LIKE GROWTH FACTOR (IGF) TRANSPORT AND UPTAKE BY INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS (IGFBPS),9
DDX58/IFIH1-MEDIATED INDUCTION OF INTERFERON-ALPHA/BETA,9
PATHWAYS AFFECTED IN ADENOID CYSTIC CARCINOMA,9
G1 TO S CELL CYCLE CONTROL,9
DOWNSTREAM SIGNAL TRANSDUCTION,9
PDGFR-BETA PATHWAY,9
INTEGRATED LUNG CANCER PATHWAY,9
CYTOSOLIC SENSORS OF PATHOGEN-ASSOCIATED DNA ,9
INTERLEUKIN-1 SIGNALING,9
SIGNALING BY THE B CELL RECEPTOR (BCR),9
CIRCADIAN CLOCK,8
INTRINSIC PATHWAY FOR APOPTOSIS,8
OXIDATIVE STRESS INDUCED SENESCENCE,8
G ALPHA (Q) SIGNALLING EVENTS,8
INTERLEUKIN-17 SIGNALING,8
MAP KINASE ACTIVATION,8
ESTROGEN-DEPENDENT NUCLEAR EVENTS DOWNSTREAM OF ESR-MEMBRANE SIGNALING,8
GROWTH HORMONE RECEPTOR SIGNALING,8
INTEGRIN-MEDIATED CELL ADHESION,8
EBV LMP1 SIGNALING,8
SIGNALING OF HEPATOCYTE GROWTH FACTOR RECEPTOR,8
PRION DISEASE PATHWAY,8
EPO RECEPTOR SIGNALING,8
"NUCLEOTIDE-BINDING DOMAIN, LEUCINE RICH REPEAT CONTAINING RECEPTOR (NLR) SIGNALING PATHWAYS",8
SIGNALING BY TGF-BETA RECEPTOR COMPLEX,8
SIGNALING BY TGF-BETA FAMILY MEMBERS,8
INTERLEUKIN RECEPTOR SHC SIGNALING,8
T-CELL RECEPTOR AND CO-STIMULATORY SIGNALING,8
ARYL HYDROCARBON RECEPTOR PATHWAY,8
INFLAMMATORY RESPONSE PATHWAY,8
DEVELOPMENT AND HETEROGENEITY OF THE ILC FAMILY,8
R-HSA-9662851,8
R-HSA-9664433,8
AMYOTROPHIC LATERAL SCLEROSIS (ALS),8
TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION,8
OVARIAN TUMOR DOMAIN PROTEASES,8
REGULATION OF TP53 DEGRADATION,8
REGULATION OF TP53 EXPRESSION AND DEGRADATION,8
CELL CYCLE CHECKPOINTS,8
DNA REPAIR,8
AMP-ACTIVATED PROTEIN KINASE (AMPK) SIGNALING,8
TP53 NETWORK,8
RETINOBLASTOMA GENE IN CANCER,8
COPPER HOMEOSTASIS,8
SIGNALING BY ERBB2,8
MITOTIC G1-G1/S PHASES,8
PRIMARY FOCAL SEGMENTAL GLOMERULOSCLEROSIS FSGS,8
SIGNALING BY EGFR,8
ER-PHAGOSOME PATHWAY,8
ANTIGEN PROCESSING-CROSS PRESENTATION,8
DISEASES OF IMMUNE SYSTEM,8
DISEASES ASSOCIATED WITH THE TLR SIGNALING CASCADE,8
SIGNALING BY MET,8
GPVI-MEDIATED ACTIVATION CASCADE,8
CELL-CELL COMMUNICATION,8
REGULATION OF SIGNALING BY CBL,8
COMPLEMENT CASCADE,7
OVERVIEW OF NANOPARTICLE EFFECTS,7
ORGANELLE BIOGENESIS AND MAINTENANCE,7
REGULATION OF HSF1-MEDIATED HEAT SHOCK RESPONSE,7
STEROL REGULATORY ELEMENT-BINDING PROTEINS (SREBP) SIGNALLING,7
SIGNALING BY FGFR,7
FCGAMMA RECEPTOR (FCGR) DEPENDENT PHAGOCYTOSIS,7
SIGNALING BY FGFR1,7
INSULIN RECEPTOR SIGNALLING CASCADE,7
SIGNALING BY INSULIN RECEPTOR,7
ANGIOGENESIS,7
ALZHEIMERS DISEASE,7
ALPHA 6 BETA 4 SIGNALING PATHWAY,7
NEOVASCULARISATION PROCESSES,7
"RELATIONSHIP BETWEEN INFLAMMATION, COX-2 AND EGFR",7
PHOTODYNAMIC THERAPY-INDUCED HIF-1 SURVIVAL SIGNALING,7
MIRNA REGULATION OF P53 PATHWAY IN PROSTATE CANCER,7
PLATELET-MEDIATED INTERACTIONS WITH VASCULAR AND CIRCULATING CELLS,7
REGULATION OF TP53 ACTIVITY THROUGH PHOSPHORYLATION,7
VITAMIN D IN INFLAMMATORY DISEASES,7
TRANSCRIPTION FACTOR REGULATION IN ADIPOGENESIS,7
P53-DEPENDENT G1 DNA DAMAGE RESPONSE,7
P53-DEPENDENT G1/S DNA DAMAGE CHECKPOINT,7
G1/S DNA DAMAGE CHECKPOINTS,7
WNT SIGNALING PATHWAY AND PLURIPOTENCY,7
TRANSCRIPTIONAL REGULATION BY THE AP-2 (TFAP2) FAMILY OF TRANSCRIPTION FACTORS,7
SIGNALING BY WNT,7
CD28 CO-STIMULATION,7
CD28 DEPENDENT PI3K/AKT SIGNALING,7
G1/S TRANSITION,7
PI3K-AKT-MTOR - VITD3 SIGNALLING,7
SIGNALING BY ERBB4,7
R-HSA-9669938,7
R-HSA-9670439,7
SIGNALING BY FGFR IN DISEASE,7
FGFR1 MUTANT RECEPTOR ACTIVATION,7
SIGNALING BY FGFR1 IN DISEASE,7
P75 NTR RECEPTOR-MEDIATED SIGNALLING,7
MICROGLIA PATHOGEN PHAGOCYTOSIS PATHWAY,7
C-TYPE LECTIN RECEPTORS (CLRS),7
ESTROGEN-DEPENDENT GENE EXPRESSION,7
INTEGRIN CELL SURFACE INTERACTIONS,7
R-HSA-9679506,6
MACROAUTOPHAGY,6
AUTOPHAGY,6
HIV INFECTION,6
ANTIMICROBIAL PEPTIDES,6
TYROBP CAUSAL NETWORK,6
REGULATION OF COMPLEMENT CASCADE,6
DENGUE-2 INTERACTIONS WITH COMPLEMENT AND COAGULATION CASCADES,6
COMPLEMENT AND COAGULATION CASCADES,6
MITOCHONDRIAL BIOGENESIS,6
ENERGY METABOLISM,6
GLUCOCORTICOID RECEPTOR PATHWAY,6
SIGNALING BY FGFR2,6
SIGNALING BY FGFR3,6
SIGNALING BY FGFR4,6
REGULATION OF PTEN GENE TRANSCRIPTION,6
PHYSIOLOGICAL AND PATHOLOGICAL HYPERTROPHY OF THE HEART,6
IL-9 SIGNALING PATHWAY,6
STRUCTURAL PATHWAY OF INTERLEUKIN 1 (IL-1),6
SEROTONIN HTR1 GROUP AND FOS PATHWAY,6
INTERLEUKIN-12 FAMILY SIGNALING,6
NO-CGMP-PKG MEDIATED NEUROPROTECTION,6
METABOLISM OF RNA,6
THERMOGENESIS,6
POST-TRANSLATIONAL PROTEIN PHOSPHORYLATION,6
POLYCYSTIC KIDNEY DISEASE PATHWAY,6
R-HSA-8853884,6
TP53 REGULATES TRANSCRIPTION OF CELL DEATH GENES,6
DNA DOUBLE-STRAND BREAK REPAIR,6
MIRNAS INVOLVED IN DNA DAMAGE RESPONSE,6
MAMMARY GLAND DEVELOPMENT PATHWAY - INVOLUTION (STAGE 4 OF 4),6
TCF DEPENDENT SIGNALING IN RESPONSE TO WNT,6
CYCLIN E ASSOCIATED EVENTS DURING G1/S TRANSITION ,6
S PHASE,6
CYCLIN A:CDK2-ASSOCIATED EVENTS AT S PHASE ENTRY,6
REGULATION OF MICROTUBULE CYTOSKELETON,6
EXTRACELLULAR VESICLE-MEDIATED SIGNALING IN RECIPIENT CELLS,6
PI3K-AKT-MTOR SIGNALING PATHWAY AND THERAPEUTIC OPPORTUNITIES,6
FACTORS AND PATHWAYS AFFECTING INSULIN-LIKE GROWTH FACTOR (IGF1)-AKT SIGNALING,6
CONSTITUTIVE SIGNALING BY LIGAND-RESPONSIVE EGFR CANCER VARIANTS,6
SIGNALING BY EGFR IN CANCER,6
SIGNALING BY LIGAND-RESPONSIVE EGFR VARIANTS IN CANCER,6
SIGNALING BY NOTCH3,6
MAMMARY GLAND DEVELOPMENT PATHWAY - PREGNANCY AND LACTATION (STAGE 3 OF 4),6
INTERLEUKIN-6 SIGNALING,6
INTERLEUKIN-6 FAMILY SIGNALING,6
ENDODERM DIFFERENTIATION,6
"FOXO-MEDIATED TRANSCRIPTION OF OXIDATIVE STRESS, METABOLIC AND NEURONAL GENES",6
WHITE FAT CELL DIFFERENTIATION,6
REGULATION OF TLR BY ENDOGENOUS LIGAND,6
SIGNALING BY CYTOSOLIC FGFR1 FUSION MUTANTS,6
DAP12 INTERACTIONS,6
SIGNALING BY TYPE 1 INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR (IGF1R),6
DAP12 SIGNALING,6
IGF1R SIGNALING CASCADE,6
IRS-RELATED EVENTS TRIGGERED BY IGF1R,6
TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX,6
TRANSCRIPTIONAL REGULATION BY MECP2,6
NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY,6
NUCLEAR RECEPTORS,6
MAMMARY GLAND DEVELOPMENT PATHWAY - PUBERTY (STAGE 2 OF 4),6
SIGNALING BY NOTCH1,6
NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION,6
ANTIGEN ACTIVATES B CELL RECEPTOR (BCR) LEADING TO GENERATION OF SECOND MESSENGERS,6
R-HSA-9663891,5
CALORIC RESTRICTION AND AGING,5
TRANSMISSION ACROSS CHEMICAL SYNAPSES,5
NEURONAL SYSTEM,5
NUCLEAR EVENTS (KINASE AND TRANSCRIPTION FACTOR ACTIVATION),5
ONCOGENE INDUCED SENESCENCE,5
L1CAM INTERACTIONS,5
NCAM SIGNALING FOR NEURITE OUT-GROWTH,5
MAPK TARGETS/ NUCLEAR EVENTS MEDIATED BY MAP KINASES,5
NEGATIVE REGULATION OF FGFR1 SIGNALING,5
HEART DEVELOPMENT,5
FOLLICLE STIMULATING HORMONE (FSH) SIGNALING PATHWAY,5
IL17 SIGNALING PATHWAY,5
HYPOTHESIZED PATHWAYS IN PATHOGENESIS OF CARDIOVASCULAR DISEASE,5
MYOMETRIAL RELAXATION AND CONTRACTION PATHWAYS,5
NUCLEOTIDE-BINDING OLIGOMERIZATION DOMAIN (NOD) PATHWAY,5
TRANSCRIPTIONAL ACTIVITY OF SMAD2/SMAD3:SMAD4 HETEROTRIMER,5
SMAD2/SMAD3:SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION,5
OXIDATIVE DAMAGE,5
RUNX1 AND FOXP3 CONTROL THE DEVELOPMENT OF REGULATORY T LYMPHOCYTES (TREGS),5
MIR-TARGETED GENES IN LEUKOCYTES - TARBASE,5
REGULATION OF IFNG SIGNALING,5
NOD1/2 SIGNALING PATHWAY,5
REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU-RICH ELEMENTS,5
CANONICAL AND NON-CANONICAL TGF-B SIGNALING,5
P38 MAPK SIGNALING PATHWAY,5
REGULATION OF TNFR1 SIGNALING,5
TNFR1-INDUCED NFKAPPAB SIGNALING PATHWAY,5
TNFR2 NON-CANONICAL NF-KB PATHWAY,5
TNF SIGNALING,5
MAMMARY GLAND DEVELOPMENT PATHWAY - EMBRYONIC DEVELOPMENT (STAGE 1 OF 4),5
FAS LIGAND (FASL) PATHWAY AND STRESS INDUCTION OF HEAT SHOCK PROTEINS (HSP) REGULATION,5
REGULATION OF IFNA SIGNALING,5
FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION,5
TP53 REGULATES METABOLIC GENES,5
RECRUITMENT AND ATM-MEDIATED PHOSPHORYLATION OF REPAIR AND SIGNALING PROTEINS AT DNA DOUBLE STRAND BREAKS,5
DNA DOUBLE STRAND BREAK RESPONSE,5
G2/M CHECKPOINTS,5
STABILIZATION OF P53,5
CELLULAR RESPONSE TO HYPOXIA,5
TYPE 2 PAPILLARY RENAL CELL CARCINOMA,5
CTLA4 INHIBITORY SIGNALING,5
CONSTITUTIVE SIGNALING BY AKT1 E17K IN CANCER,5
SIGNALING BY NOTCH4,5
MECP2 AND ASSOCIATED RETT SYNDROME,5
LEPTIN INSULIN OVERLAP,5
GAB1 SIGNALOSOME,5
EGFR DOWNREGULATION,5
CONSTITUTIVE SIGNALING BY EGFRVIII,5
SIGNALING BY EGFRVIII IN CANCER,5
HAIR FOLLICLE DEVELOPMENT- INDUCTION (PART 1 OF 3),5
MYD88 DEFICIENCY (TLR2/4),5
IRAK4 DEFICIENCY (TLR2/4),5
ACTIVATION OF IRF3/IRF7 MEDIATED BY TBK1/IKK EPSILON,5
IKK COMPLEX RECRUITMENT MEDIATED BY RIP1,5
PATHOGENIC ESCHERICHIA COLI INFECTION,5
DEGRADATION OF THE EXTRACELLULAR MATRIX,5
R-HSA-9671555,5
R-HSA-9673767,5
R-HSA-9673770,5
SIGNALING BY LEPTIN,5
INTERLEUKIN-20 FAMILY SIGNALING,5
TRANSCRIPTIONAL REGULATION OF GRANULOPOIESIS,5
WNT SIGNALING,5
PI3K CASCADE,5
IRS-MEDIATED SIGNALLING,5
PI3K/AKT ACTIVATION,5
ROLE OF LAT2/NTAL/LAB ON CALCIUM MOBILIZATION,5
SIGNALING BY ERYTHROPOIETIN,5
ZBP1(DAI) MEDIATED INDUCTION OF TYPE I IFNS,5
CLEC7A (DECTIN-1) SIGNALING,5
TRAF6 MEDIATED NF-KB ACTIVATION,5
"GPCRS, CLASS A RHODOPSIN-LIKE",5
SUMOYLATION OF INTRACELLULAR RECEPTORS,5
CYCLIN D ASSOCIATED EVENTS IN G1,5
G1 PHASE,5
SIGNALING BY NOTCH1 PEST DOMAIN MUTANTS IN CANCER,5
SIGNALING BY NOTCH1 IN CANCER,5
CONSTITUTIVE SIGNALING BY NOTCH1 PEST DOMAIN MUTANTS,5
SIGNALING BY NOTCH1 HD+PEST DOMAIN MUTANTS IN CANCER,5
CONSTITUTIVE SIGNALING BY NOTCH1 HD+PEST DOMAIN MUTANTS,5
NEURAL CREST DIFFERENTIATION,5
REGULATION OF KIT SIGNALING,5
PPARA ACTIVATES GENE EXPRESSION,5
REGULATION OF LIPID METABOLISM BY PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA (PPARALPHA),5
ISG15 ANTIVIRAL MECHANISM,5
ANTIVIRAL MECHANISM BY IFN-STIMULATED GENES,5
R-HSA-9679191,4
METABOLISM OF ANGIOTENSINOGEN TO ANGIOTENSINS,4
ACE INHIBITOR PATHWAY,4
HIV LIFE CYCLE,4
HOST INTERACTIONS OF HIV FACTORS,4
PD-1 SIGNALING,4
TRANSCRIPTIONAL ACTIVATION OF MITOCHONDRIAL BIOGENESIS,4
SOMATROPH AXIS (GH) AND ITS RELATIONSHIP TO DIETARY RESTRICTION AND AGING,4
R-HSA-9635486,4
R-HSA-9664407,4
R-HSA-9664417,4
R-HSA-9664422,4
OPIOID SIGNALLING,4
NEUROTRANSMITTER RECEPTORS AND POSTSYNAPTIC SIGNAL TRANSMISSION,4
SPRY REGULATION OF FGF SIGNALING,4
SIGNALLING TO ERKS,4
FCERI MEDIATED MAPK ACTIVATION,4
SIGNAL TRANSDUCTION BY L1,4
ACTIVATION OF THE AP-1 FAMILY OF TRANSCRIPTION FACTORS,4
NEGATIVE REGULATION OF FGFR2 SIGNALING,4
NEGATIVE REGULATION OF FGFR3 SIGNALING,4
NEGATIVE REGULATION OF FGFR4 SIGNALING,4
ONCOGENIC MAPK SIGNALING,4
TYPE II DIABETES MELLITUS,4
BDNF-TRKB SIGNALING,4
"ERK PATHWAY IN HUNTINGTON,S DISEASE",4
SEROTONIN RECEPTOR 4-6-7 AND NR3C SIGNALING,4
R-HSA-9660826,4
R-HSA-9664424,4
ECM PROTEOGLYCANS,4
ECTODERM DIFFERENTIATION,4
INTERLEUKIN-2 SIGNALING,4
GENE AND PROTEIN EXPRESSION BY JAK-STAT SIGNALING AFTER INTERLEUKIN-12 STIMULATION,4
INTERLEUKIN-12 SIGNALING,4
NETRIN-1 SIGNALING,4
ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION,4
OXIDATIVE STRESS,4
MONOAMINE TRANSPORT,4
AMYLOID FIBER FORMATION,4
MATRIX METALLOPROTEINASES,4
ROLE ALTERED GLYCOLYSATION OF MUC1 IN TUMOUR MICROENVIRONMENT,4
TRAF6 MEDIATED IRF7 ACTIVATION,4
ACTIVATION OF BH3-ONLY PROTEINS,4
PRE-NOTCH TRANSCRIPTION AND TRANSLATION,4
PRE-NOTCH EXPRESSION AND PROCESSING,4
DNA DAMAGE/TELOMERE STRESS INDUCED SENESCENCE,4
MITOTIC G2-G2/M PHASES,4
TP53 REGULATES TRANSCRIPTION OF CELL CYCLE GENES,4
TP53 REGULATES TRANSCRIPTION OF DNA REPAIR GENES,4
TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN CYTOCHROME C RELEASE,4
REGULATION OF TP53 ACTIVITY THROUGH METHYLATION,4
G2/M TRANSITION,4
RUNX3 REGULATES CDKN1A TRANSCRIPTION,4
GASTRIC CANCER NETWORK 2,4
ATM SIGNALING PATHWAY,4
FERROPTOSIS,4
REGULATION OF GENE EXPRESSION BY HYPOXIA-INDUCIBLE FACTOR,4
TFAP2 (AP-2) FAMILY REGULATES TRANSCRIPTION OF GROWTH FACTORS AND THEIR RECEPTORS,4
AMPLIFICATION AND EXPANSION OF ONCOGENIC PATHWAYS AS METASTATIC TRAITS,4
REGULATION OF BETA-CELL DEVELOPMENT,4
INTEGRIN ALPHAIIB BETA3 SIGNALING,4
DEACTIVATION OF THE BETA-CATENIN TRANSACTIVATING COMPLEX,4
PLATELET AGGREGATION (PLUG FORMATION),4
DOWNREGULATION OF ERBB2 SIGNALING,4
REGULATION OF APOPTOSIS BY PARATHYROID HORMONE-RELATED PROTEIN,4
STEATOSIS AOP,4
R-HSA-1227990,4
R-HSA-9664565,4
R-HSA-9665348,4
PI3K EVENTS IN ERBB2 SIGNALING,4
R-HSA-9660821,4
TLR4 SIGNALING AND TOLERANCE,4
TGF-BETA RECEPTOR SIGNALING ACTIVATES SMADS,4
REGULATION OF RUNX3 EXPRESSION AND ACTIVITY,4
NRF2 PATHWAY,4
CASPASE ACTIVATION VIA DEATH RECEPTORS IN THE PRESENCE OF LIGAND,4
CASPASE ACTIVATION VIA EXTRINSIC APOPTOTIC SIGNALLING PATHWAY,4
SIMPLIFIED DEPICTION OF MYD88 DISTINCT INPUT-OUTPUT PATHWAY,4
ACTIVATION OF MATRIX METALLOPROTEINASES,4
EPH-EPHRIN SIGNALING,4
INTERLEUKIN-7 SIGNALING,4
INTERLEUKIN-9 SIGNALING,4
INTERLEUKIN-37 SIGNALING,4
R-HSA-9664323,4
JNK (C-JUN KINASES) PHOSPHORYLATION AND  ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1,4
NLR PROTEINS,4
METABOLISM OF STEROIDS,4
RIPK1-MEDIATED REGULATED NECROSIS,4
REGULATED NECROSIS,4
REGULATION OF NECROPTOTIC CELL DEATH,4
PI METABOLISM,4
PHOSPHOLIPID METABOLISM,4
SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE,4
ROLE OF PHOSPHOLIPIDS IN PHAGOCYTOSIS,4
TIE2 SIGNALING,4
NEPHRIN FAMILY INTERACTIONS,4
DOWNSTREAM SIGNALING OF ACTIVATED FGFR1,4
PI-3K CASCADE:FGFR1,4
RET SIGNALING,4
SIGNALING BY NTRK2 (TRKB),4
ERYTHROPOIETIN ACTIVATES PHOSPHOINOSITIDE-3-KINASE (PI3K),4
RIP-MEDIATED NFKB ACTIVATION VIA ZBP1,4
P75NTR SIGNALS VIA NF-KB,4
CHROMATIN MODIFYING ENZYMES,4
CHROMATIN ORGANIZATION,4
SUPRESSION OF HMGB1 MEDIATED INFLAMMATION BY THBD,4
SIGNALING BY ROBO RECEPTORS,4
PEPTIDE GPCRS,4
HEMATOPOIETIC STEM CELL GENE REGULATION BY GABP ALPHA-BETA COMPLEX,4
REGULATION OF RUNX2 EXPRESSION AND ACTIVITY,4
NEDDYLATION,4
ATM SIGNALING NETWORK IN DEVELOPMENT AND DISEASE,4
SCF(SKP2)-MEDIATED DEGRADATION OF P27/P21,4
LIVER STEATOSIS AOP,4
FORMATION OF THE BETA-CATENIN:TCF TRANSACTIVATING COMPLEX,4
DEGRADATION OF BETA-CATENIN BY THE DESTRUCTION COMPLEX,4
BETA-CATENIN INDEPENDENT WNT SIGNALING,4
PARKIN-UBIQUITIN PROTEASOMAL SYSTEM PATHWAY,4
"TICAM1, RIP1-MEDIATED IKK COMPLEX RECRUITMENT ",4
OVARIAN INFERTILITY GENES,4
HOMOLOGY DIRECTED REPAIR,4
HDR THROUGH HOMOLOGOUS RECOMBINATION (HRR) OR SINGLE STRAND ANNEALING (SSA),4
PROCESSING OF DNA DOUBLE-STRAND BREAK ENDS,4
LISTERIA MONOCYTOGENES ENTRY INTO HOST CELLS,4
IRON UPTAKE AND TRANSPORT,4
R-HSA-9678108,3
DISORDERS OF TRANSMEMBRANE TRANSPORTERS,3
CHAPERONE MEDIATED AUTOPHAGY,3
MICROAUTOPHAGY,3
DEFENSINS,3
EARLY PHASE OF HIV LIFE CYCLE,3
THE ROLE OF NEF IN HIV-1 REPLICATION AND DISEASE PATHOGENESIS,3
BINDING AND ENTRY OF HIV VIRION,3
PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS,3
NAD+ METABOLISM,3
NAD+ BIOSYNTHETIC PATHWAYS,3
SREBF AND MIR33 IN CHOLESTEROL AND LIPID HOMEOSTASIS,3
"NAD METABOLISM, SIRTUINS AND AGING",3
R-HSA-9637690,3
R-HSA-9649948,3
APOPTOTIC FACTOR-MEDIATED RESPONSE,3
CA-DEPENDENT EVENTS,3
G-PROTEIN MEDIATED EVENTS,3
PLC BETA MEDIATED EVENTS,3
RAF-INDEPENDENT MAPK1/3 ACTIVATION,3
MAPK1 (ERK2) ACTIVATION,3
PROLONGED ERK ACTIVATION EVENTS,3
REGULATION OF ACTIN DYNAMICS FOR PHAGOCYTIC CUP FORMATION,3
POST NMDA RECEPTOR ACTIVATION EVENTS,3
ACTIVATION OF NMDA RECEPTORS AND POSTSYNAPTIC EVENTS,3
RHO GTPASES ACTIVATE NADPH OXIDASES,3
SIGNALING BY MODERATE KINASE ACTIVITY BRAF MUTANTS,3
SIGNALING BY RAS MUTANTS,3
SIGNALING BY BRAF AND RAF FUSIONS,3
PARADOXICAL ACTIVATION OF RAF SIGNALING BY KINASE INACTIVE BRAF,3
M PHASE,3
ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING,3
GASTRIN-CREB SIGNALLING PATHWAY VIA PKC AND MAPK,3
OSTEOPONTIN SIGNALING,3
TCA CYCLE NUTRIENT UTILIZATION AND INVASIVENESS OF OVARIAN CANCER,3
TGF-B SIGNALING IN THYROID CELLS FOR EPITHELIAL-MESENCHYMAL TRANSITION,3
"4-HYDROXYTAMOXIFEN, DEXAMETHASONE, AND RETINOIC ACIDS REGULATION OF P27 EXPRESSION",3
INFLAMMASOMES,3
BLOOD CLOTTING CASCADE,3
NOTCH1 REGULATION OF HUMAN ENDOTHELIAL CELL CALCIFICATION,3
DENGUE-2 INTERACTIONS WITH BLOOD CLOTTING CASCADE,3
"BMAL1:CLOCK,NPAS2 ACTIVATES CIRCADIAN GENE EXPRESSION",3
PERK REGULATES GENE EXPRESSION,3
UNFOLDED PROTEIN RESPONSE (UPR),3
ASPARAGINE N-LINKED GLYCOSYLATION,3
PROTEASOME DEGRADATION,3
R-HSA-9662834,3
PLATELET HOMEOSTASIS,3
PLATELET SENSITIZATION BY LDL,3
PHOTODYNAMIC THERAPY-INDUCED NFE2L2 (NRF2) SURVIVAL SIGNALING,3
METABOLISM OF VITAMINS AND COFACTORS,3
SUMOYLATION OF TRANSCRIPTION FACTORS,3
AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1,3
TP53 REGULATES TRANSCRIPTION OF DEATH RECEPTORS AND LIGANDS,3
TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN G1 CELL CYCLE ARREST,3
REGULATION OF TP53 ACTIVITY THROUGH ACETYLATION,3
G2/M DNA DAMAGE CHECKPOINT,3
THE ROLE OF GTSE1 IN G2/M PROGRESSION AFTER G2 CHECKPOINT,3
LNCRNA-MEDIATED MECHANISMS OF THERAPEUTIC RESISTANCE,3
HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CARCINOMA PATHWAY,3
QUERCETIN AND NF-KB- AP-1 INDUCED CELL APOPTOSIS,3
AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL,3
VEGFR2 MEDIATED VASCULAR PERMEABILITY,3
PTK6 REGULATES RTKS AND THEIR EFFECTORS AKT1 AND DOK1,3
REGULATION OF PTEN STABILITY AND ACTIVITY,3
TFS REGULATE MIRNAS RELATED TO CARDIAC HYPERTROPHY,3
ERBB2 REGULATES CELL MOTILITY,3
NOTCH3 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS,3
NCRNAS INVOLVED IN STAT3 SIGNALING IN HEPATOCELLULAR CARCINOMA,3
INFLUENZA LIFE CYCLE,3
DOWNREGULATION OF TGF-BETA RECEPTOR SIGNALING,3
TGF-BETA RECEPTOR SIGNALING IN EMT (EPITHELIAL TO MESENCHYMAL TRANSITION),3
DOPAMINERGIC NEUROGENESIS,3
"SYNTHESIS, SECRETION, AND DEACYLATION OF GHRELIN",3
PROTEIN LOCALIZATION,3
TRAF6-MEDIATED INDUCTION OF TAK1 COMPLEX WITHIN TLR4 COMPLEX,3
IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7/8 OR 9 STIMULATION,3
APOE AND MIR-146 IN INFLAMMATION AND ATHEROSCLEROSIS,3
COLLAGEN DEGRADATION,3
COLLAGEN FORMATION,3
EPH-EPHRIN MEDIATED REPULSION OF CELLS,3
INTERLEUKIN-21 SIGNALING,3
ESTROGEN RECEPTOR PATHWAY,3
"CELL DEATH SIGNALLING VIA NRAGE, NRIF AND NADE",3
NRIF SIGNALS CELL DEATH FROM THE NUCLEUS,3
WNT SIGNALING IN KIDNEY DISEASE,3
AOP CYP2E1 ACTIVATION LEADING TO NEURODEGENERATION,3
NRF2-ARE REGULATION,3
G ALPHA (S) SIGNALLING EVENTS,3
DISEASES OF METABOLISM,3
NANOMATERIAL INDUCED APOPTOSIS,3
PI-3K CASCADE:FGFR2,3
DOWNSTREAM SIGNALING OF ACTIVATED FGFR2,3
DOWNSTREAM SIGNALING OF ACTIVATED FGFR3,3
PI-3K CASCADE:FGFR3,3
DOWNSTREAM SIGNALING OF ACTIVATED FGFR4,3
PI-3K CASCADE:FGFR4,3
SIGNALING BY NTRK3 (TRKC),3
G13 SIGNALING PATHWAY,3
DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR (BCR),3
ACTIVATION OF NF-KAPPAB IN B CELLS,3
NF-KB IS ACTIVATED AND SIGNALS SURVIVAL,3
FCERI MEDIATED NF-KB ACTIVATION,3
CD209 (DC-SIGN) SIGNALING,3
INITIATION OF TRANSCRIPTION AND TRANSLATION ELONGATION AT THE HIV-1 LTR,3
R-HSA-9031628,3
HSP90 CHAPERONE CYCLE FOR STEROID HORMONE RECEPTORS (SHR),3
RHO GTPASES ACTIVATE PKNS,3
METABOLISM OF CARBOHYDRATES,3
HSF1-DEPENDENT TRANSACTIVATION,3
R-HSA-9659787,3
R-HSA-9661069,3
R-HSA-9675126,3
R-HSA-9687139,3
P75NTR RECRUITS SIGNALLING COMPLEXES,3
TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7/8 OR 9 SIGNALING,3
G0 AND EARLY G1,3
MAPK6/MAPK4 SIGNALING,3
RUNX3 REGULATES WNT SIGNALING,3
PPAR ALPHA PATHWAY,3
IMATINIB AND CHRONIC MYELOID LEUKEMIA,3
LNCRNA INVOLVEMENT IN CANONICAL WNT SIGNALING AND COLORECTAL CANCER,3
NCRNAS INVOLVED IN WNT SIGNALING IN HEPATOCELLULAR CARCINOMA,3
PROLACTIN RECEPTOR SIGNALING,3
PECAM1 INTERACTIONS,3
METABOLISM OF AMINO ACIDS AND DERIVATIVES,3
TICAM1-DEPENDENT ACTIVATION OF IRF3/IRF7,3
MECP2 REGULATES TRANSCRIPTION OF NEURONAL LIGANDS,3
R-HSA-9664873,3
REPRODUCTION,3
MEIOSIS,3
HDR THROUGH HOMOLOGOUS RECOMBINATION (HRR),3
MEIOTIC RECOMBINATION,3
HEDGEHOG SIGNALING PATHWAY,3
LRR FLII-INTERACTING PROTEIN 1 (LRRFIP1) ACTIVATES TYPE I IFN PRODUCTION,3
NOTCH-HLH TRANSCRIPTION PATHWAY,3
NOTCH3 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION,3
NOTCH4 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION,3
TRAF3-DEPENDENT IRF ACTIVATION PATHWAY,3
NOTCH SIGNALING,3
CILIARY LANDSCAPE,3
APOPTOTIC EXECUTION PHASE,3
CD28 DEPENDENT VAV1 PATHWAY,3
TRANS-GOLGI NETWORK VESICLE BUDDING,3
NEGATIVE REGULATION OF MET ACTIVITY,3
INLB-MEDIATED ENTRY OF LISTERIA MONOCYTOGENES INTO HOST CELL,3
SEMAPHORIN INTERACTIONS,3
PPAR SIGNALING PATHWAY,3
MESODERMAL COMMITMENT PATHWAY,3
RHO GTPASE CYCLE,3
INTERFERON ALPHA-BETA SIGNALING,3
NEGATIVE REGULATORS OF DDX58/IFIH1 SIGNALING,3
AUF1 (HNRNP D0) BINDS AND DESTABILIZES MRNA,3
DOWNREGULATION OF SMAD2/3:SMAD4 TRANSCRIPTIONAL ACTIVITY,3
INITIAL TRIGGERING OF COMPLEMENT,2
R-HSA-9678110,2
R-HSA-9646399,2
ABC-FAMILY PROTEINS MEDIATED TRANSPORT,2
ABC TRANSPORTER DISORDERS,2
DEFECTIVE CFTR CAUSES CYSTIC FIBROSIS,2
NEF-MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS,2
VPU MEDIATED DEGRADATION OF CD4,2
TRANSLOCATION OF ZAP-70 TO IMMUNOLOGICAL SYNAPSE,2
GENERATION OF SECOND MESSENGER MOLECULES,2
OTHER INTERLEUKIN SIGNALING,2
EPIGENETIC REGULATION OF GENE EXPRESSION,2
NEGATIVE EPIGENETIC REGULATION OF RRNA EXPRESSION,2
REGULATION OF FOXO TRANSCRIPTIONAL ACTIVITY BY ACETYLATION,2
SIMPLIFIED INTERACTION MAP BETWEEN LOXL4 AND OXIDATIVE STRESS PATHWAY,2
R-HSA-9656223,2
FRS2-MEDIATED ACTIVATION,2
ERK/MAPK TARGETS,2
CREB1 PHOSPHORYLATION THROUGH NMDA RECEPTOR-MEDIATED ACTIVATION OF RAS SIGNALING,2
MAP2K AND MAPK ACTIVATION,2
NEGATIVE REGULATION OF MAPK PATHWAY,2
SIGNALING BY HIGH-KINASE ACTIVITY BRAF MUTANTS,2
SIGNAL ATTENUATION,2
RUNX2 REGULATES OSTEOBLAST DIFFERENTIATION,2
RUNX2 REGULATES BONE DEVELOPMENT,2
NIFEDIPINE ACTIVITY,2
SIGNAL TRANSDUCTION OF S1P RECEPTOR,2
COMMON PATHWAYS UNDERLYING DRUG ADDICTION,2
MFAP5-MEDIATED OVARIAN CANCER CELL MOTILITY AND INVASIVENESS,2
MAPK AND NFKB SIGNALLING PATHWAYS INHIBITED BY YERSINIA YOPJ,2
MAPK CASCADE,2
INHIBITION OF EXOSOME BIOGENESIS AND SECRETION BY MANUMYCIN A IN CRPC CELLS,2
VITAMIN A AND CAROTENOID METABOLISM,2
ION CHANNEL TRANSPORT,2
THE NLRP3 INFLAMMASOME,2
DISSOLUTION OF FIBRIN CLOT,2
TRANSCRIPTIONAL ACTIVITY OF SMAD2-SMAD3-SMAD4 HETEROTRIMER,2
"BMAL1-CLOCK,NPAS2 ACTIVATES CIRCADIAN GENE EXPRESSION",2
ACTIVATION OF C3 AND C5,2
COMPLEMENT ACTIVATION,2
ATF4 ACTIVATES GENES IN RESPONSE TO ENDOPLASMIC RETICULUM  STRESS,2
ATF4 ACTIVATES GENES,2
ER TO GOLGI ANTEROGRADE TRANSPORT,2
MHC CLASS II ANTIGEN PRESENTATION,2
TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION,2
HYPERTROPHY MODEL,2
SIGNALLING TO RAS,2
DSCAM INTERACTIONS,2
KSRP (KHSRP) BINDS AND DESTABILIZES MRNA,2
MYOGENESIS,2
PARKINSONS DISEASE PATHWAY,2
INTERLEUKIN-18 SIGNALING,2
VISUAL PHOTOTRANSDUCTION,2
THE CANONICAL RETINOID CYCLE IN RODS (TWILIGHT VISION),2
NON-INTEGRIN MEMBRANE-ECM INTERACTIONS,2
METABOLISM OF NUCLEOTIDES,2
MITOTIC METAPHASE AND ANAPHASE,2
MITOTIC ANAPHASE,2
TNFR1-INDUCED PROAPOPTOTIC SIGNALING,2
TNFR1-MEDIATED CERAMIDE PRODUCTION,2
CHAPERONIN-MEDIATED PROTEIN FOLDING,2
ASSOCIATION OF TRIC/CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS,2
PROTEIN FOLDING,2
TP53 REGULATES TRANSCRIPTION OF CASPASE ACTIVATORS AND CASPASES,2
TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN G2 CELL CYCLE ARREST,2
REGULATION OF TP53 ACTIVITY THROUGH ASSOCIATION WITH CO-FACTORS,2
TRANSCRIPTIONAL ACTIVATION OF P53 RESPONSIVE GENES  ,2
TRANSCRIPTIONAL  ACTIVATION OF  CELL CYCLE INHIBITOR P21 ,2
METASTATIC BRAIN TUMOR,2
THE EFFECT OF PROGERIN ON THE INVOLVED GENES IN HUTCHINSON-GILFORD PROGERIA SYNDROME,2
MICRORNA NETWORK ASSOCIATED WITH CHRONIC LYMPHOCYTIC LEUKEMIA,2
REGULATION OF HYPOXIA-INDUCIBLE FACTOR (HIF) BY OXYGEN,2
MICRORNA FOR TARGETING CANCER GROWTH AND VASCULARIZATION IN GLIOBLASTOMA,2
ACTIVATION OF BAD AND TRANSLOCATION TO MITOCHONDRIA ,2
DOWNREGULATION OF ERBB2:ERBB3 SIGNALING,2
MTOR SIGNALLING,2
AKT PHOSPHORYLATES TARGETS IN THE NUCLEUS,2
REGULATION OF GENE EXPRESSION IN BETA CELLS,2
G BETA:GAMMA SIGNALLING THROUGH PI3KGAMMA,2
G-PROTEIN BETA:GAMMA SIGNALLING,2
NEGATIVE REGULATION OF NOTCH4 SIGNALING,2
TARGET OF RAPAMYCIN (TOR) SIGNALING,2
WNT-BETA-CATENIN SIGNALING PATHWAY IN LEUKEMIA,2
R-HSA-9609646,2
R-HSA-9609690,2
R-HSA-9665686,2
SHC1 EVENTS IN ERBB2 SIGNALING,2
PLCG1 EVENTS IN ERBB2 SIGNALING,2
GRB2 EVENTS IN EGFR SIGNALING,2
SHC1 EVENTS IN EGFR SIGNALING,2
GRB2 EVENTS IN ERBB2 SIGNALING,2
EGFR INTERACTS WITH PHOSPHOLIPASE C-GAMMA,2
SIGNALING BY OVEREXPRESSED WILD-TYPE EGFR IN CANCER,2
INHIBITION OF SIGNALING BY OVEREXPRESSED EGFR,2
ERBB2 ACTIVATES PTK6 SIGNALING,2
PTK6 PROMOTES HIF1A STABILIZATION,2
BMP SIGNALING PATHWAY IN EYELID DEVELOPMENT,2
MAPK3 (ERK1) ACTIVATION,2
ELASTIC FIBRE FORMATION,2
LOSS OF FUNCTION OF SMAD2/3 IN CANCER,2
SIGNALING BY TGF-BETA RECEPTOR COMPLEX IN CANCER,2
SMAD2/3 PHOSPHORYLATION MOTIF MUTANTS IN CANCER,2
TGFBR1 KD MUTANTS IN CANCER,2
LOSS OF FUNCTION OF TGFBR1 IN CANCER,2
UCH PROTEINASES,2
RUNX3 REGULATES P14-ARF,2
INTEGRATION OF ENERGY METABOLISM,2
REGULATION OF INSULIN SECRETION,2
CORI CYCLE,2
DETOXIFICATION OF REACTIVE OXYGEN SPECIES,2
PEROXISOMAL PROTEIN IMPORT,2
TRYPTOPHAN METABOLISM,2
TRIF-MEDIATED PROGRAMMED CELL DEATH,2
NANOMATERIAL INDUCED INFLAMMASOME ACTIVATION,2
ASSEMBLY OF COLLAGEN FIBRILS AND OTHER MULTIMERIC STRUCTURES,2
BH3-ONLY PROTEINS ASSOCIATE WITH AND INACTIVATE ANTI-APOPTOTIC BCL-2 MEMBERS,2
SIGNALLING TO STAT3,2
PTK6 ACTIVATES STAT3,2
INTERLEUKIN-15 SIGNALING,2
INTERLEUKIN-35 SIGNALLING,2
INTERLEUKIN-27 SIGNALING,2
DEVELOPMENT OF PULMONARY DENDRITIC CELLS AND MACROPHAGE SUBSETS,2
NANOPARTICLE TRIGGERED REGULATED NECROSIS,2
PHYTOCHEMICAL ACTIVITY ON NRF2 TRANSCRIPTIONAL ACTIVATION,2
"SYNTHESIS, SECRETION, AND INACTIVATION OF GLUCAGON-LIKE PEPTIDE-1 (GLP-1)",2
"INCRETIN SYNTHESIS, SECRETION, AND INACTIVATION",2
DIFFERENTIATION OF WHITE AND BROWN ADIPOCYTE,2
BIOLOGICAL OXIDATIONS,2
CYTOCHROME P450 - ARRANGED BY SUBSTRATE TYPE,2
PHASE I - FUNCTIONALIZATION OF COMPOUNDS,2
ENDOGENOUS STEROLS,2
SEROTONIN AND ANXIETY,2
REGULATION BY C-FLIP,2
CASP8 ACTIVITY IS INHIBITED,2
DIMERIZATION OF PROCASPASE-8,2
APOPTOSIS MODULATION BY HSP70,2
PI3K EVENTS IN ERBB4 SIGNALING,2
SIGNALING BY FGFR2 IN DISEASE,2
SIGNALING BY FGFR4 IN DISEASE,2
SIGNALING BY FGFR3 IN DISEASE,2
MET ACTIVATES PI3K/AKT SIGNALING,2
SIGNALING BY FGFR3 FUSIONS IN CANCER,2
SIGNALING BY FGFR3 POINT MUTANTS IN CANCER,2
ACTIVATED NTRK2 SIGNALS THROUGH PI3K,2
ACTIVATED NTRK3 SIGNALS THROUGH PI3K,2
TNF RECEPTOR SUPERFAMILY (TNFSF) MEMBERS MEDIATING NON-CANONICAL NF-KB PATHWAY,2
BINDING AND UPTAKE OF LIGANDS BY SCAVENGER RECEPTORS,2
SLC-MEDIATED TRANSMEMBRANE TRANSPORT,2
DEX/H-BOX HELICASES ACTIVATE TYPE I IFN AND INFLAMMATORY CYTOKINES PRODUCTION ,2
INTERLEUKIN-1 PROCESSING,2
SUMOYLATION OF IMMUNE RESPONSE PROTEINS,2
IKBA VARIANT LEADS TO EDA-ID,2
DECTIN-1 MEDIATED NONCANONICAL NF-KB SIGNALING,2
CLEC7A/INFLAMMASOME PATHWAY,2
SELENIUM METABOLISM AND SELENOPROTEINS,2
REGULATION OF PTEN LOCALIZATION,2
NUCLEAR SIGNALING BY ERBB4,2
RUNX1 REGULATES TRANSCRIPTION OF GENES INVOLVED IN WNT SIGNALING,2
ARMS-MEDIATED ACTIVATION,2
P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS,2
"PTK6 REGULATES RHO GTPASES, RAS GTPASE AND MAP KINASES",2
RETT SYNDROME CAUSING GENES,2
"GPCRS, OTHER",2
ACTIVATED PKN1 STIMULATES TRANSCRIPTION OF AR (ANDROGEN RECEPTOR) REGULATED GENES KLK2 AND KLK3,2
TFAP2 (AP-2) FAMILY REGULATES TRANSCRIPTION OF CELL CYCLE FACTORS,2
FOXO-MEDIATED TRANSCRIPTION OF CELL CYCLE GENES,2
INTEGRATED CANCER PATHWAY,2
GENOTOXICITY PATHWAY,2
DOPAMINE METABOLISM,2
TRANSCRIPTION OF E2F TARGETS UNDER NEGATIVE CONTROL BY DREAM COMPLEX,2
BINDING OF TCF/LEF:CTNNB1 TO TARGET GENE PROMOTERS,2
LET-7 INHIBITION OF ES CELL REPROGRAMMING,2
SIGNAL REGULATORY PROTEIN FAMILY INTERACTIONS,2
FRS-MEDIATED FGFR1 SIGNALING,2
REGULATION OF RUNX1 EXPRESSION AND ACTIVITY,2
STAT5 ACTIVATION,2
ERYTHROPOIETIN ACTIVATES STAT5,2
AMINO ACID METABOLISM,2
TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR,2
"TICAM1,TRAF6-DEPENDENT INDUCTION OF TAK1 COMPLEX",2
HDR THROUGH SINGLE STRAND ANNEALING (SSA),2
RESOLUTION OF D-LOOP STRUCTURES,2
RESOLUTION OF D-LOOP STRUCTURES THROUGH SYNTHESIS-DEPENDENT STRAND ANNEALING (SDSA),2
RESOLUTION OF D-LOOP STRUCTURES THROUGH HOLLIDAY JUNCTION INTERMEDIATES,2
NONHOMOLOGOUS END-JOINING (NHEJ),2
HOMOLOGOUS DNA PAIRING AND STRAND EXCHANGE,2
PRESYNAPTIC PHASE OF HOMOLOGOUS DNA PAIRING AND STRAND EXCHANGE,2
ADHERENS JUNCTIONS INTERACTIONS,2
CELL-CELL JUNCTION ORGANIZATION,2
CELL JUNCTION ORGANIZATION,2
CALMODULIN INDUCED EVENTS,2
CAM PATHWAY,2
DAG AND IP3 SIGNALING,2
SIGNALING BY HEDGEHOG,2
HEDGEHOG 'ON' STATE,2
CD22 MEDIATED BCR REGULATION,2
SUMOYLATION OF DNA DAMAGE RESPONSE AND REPAIR PROTEINS,2
RORA ACTIVATES GENE EXPRESSION,2
REGULATION OF CHOLESTEROL BIOSYNTHESIS BY SREBP (SREBF),2
REGULATION OF GENE EXPRESSION IN LATE STAGE (BRANCHING MORPHOGENESIS) PANCREATIC BUD PRECURSOR CELLS,2
ACTIVATION OF GENE EXPRESSION BY SREBF (SREBP),2
ATTENUATION PHASE,2
RUNX1 REGULATES TRANSCRIPTION OF GENES INVOLVED IN DIFFERENTIATION OF MYELOID CELLS,2
RUNX3 REGULATES NOTCH SIGNALING,2
BETA DEFENSINS,2
METALLOPROTEASE DUBS,2
R-HSA-9636383,2
R-HSA-9637687,2
LYSOSOME VESICLE BIOGENESIS,2
ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT (ESCRT),2
APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS,2
NUCLEAR RECEPTORS IN LIPID METABOLISM AND TOXICITY,2
GASTRIC ULCER FORMATION,2
PROSTAGLANDIN SYNTHESIS AND REGULATION,2
UBIQUITIN-DEPENDENT DEGRADATION OF CYCLIN D,2
PTK6 REGULATES CELL CYCLE,2
H19 ACTION RB-E2F1 SIGNALING AND CDK-BETA-CATENIN ACTIVITY,2
FCGR ACTIVATION,2
DECTIN-2 FAMILY,2
MECP2 REGULATES TRANSCRIPTION FACTORS,2
HIF1A AND PPARG REGULATION OF GLYCOLYSIS,2
EPHB-MEDIATED FORWARD SIGNALING,2
EPHA-MEDIATED GROWTH CONE COLLAPSE,2
PCP/CE PATHWAY,2
RHO GTPASES ACTIVATE FORMINS,2
OXYGEN-DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA-INDUCIBLE FACTOR ALPHA,2
PTK6 EXPRESSION,2
THE HUMAN IMMUNE RESPONSE TO TUBERCULOSIS,2
"ANTIGEN PRESENTATION: FOLDING, ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC",2
STING MEDIATED INDUCTION OF HOST IMMUNE RESPONSES,2
REGULATION OF INNATE IMMUNE RESPONSES TO CYTOSOLIC DNA,2
MITOPHAGY,2
PINK/PARKIN MEDIATED MITOPHAGY,2
SIGNALING BY NOTCH2,2
REGULATION OF MECP2 EXPRESSION AND ACTIVITY,2
MECP2 REGULATES NEURONAL RECEPTORS AND CHANNELS,2
ANTIGEN PROCESSING: UBIQUITINATION & PROTEASOME DEGRADATION,2
MIR-TARGETED GENES IN SQUAMOUS CELL - TARBASE,2
INLA-MEDIATED ENTRY OF LISTERIA MONOCYTOGENES INTO HOST CELLS,2
ROLE OF OSX AND MIRNAS IN TOOTH DEVELOPMENT,2
PTF1A RELATED REGULATORY PATHWAY,2
R-HSA-9637628,2
CANNABINOID RECEPTOR SIGNALING,2
GP1B-IX-V ACTIVATION SIGNALLING,2
TRANSLESION SYNTHESIS BY Y FAMILY DNA POLYMERASES BYPASSES LESIONS ON DNA TEMPLATE,2
TERMINATION OF TRANSLESION DNA SYNTHESIS,2
DNA DAMAGE BYPASS,2
NF-KB ACTIVATION THROUGH FADD/RIP-1 PATHWAY MEDIATED BY CASPASE-8 AND -10,2
APC/C-MEDIATED DEGRADATION OF CELL CYCLE PROTEINS,2
REGULATION OF APC/C ACTIVATORS BETWEEN G1/S AND EARLY ANAPHASE,2
ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS,2
SIGNALING BY NOTCH1 HD DOMAIN MUTANTS IN CANCER,2
CONSTITUTIVE SIGNALING BY NOTCH1 HD DOMAIN MUTANTS,2
REGULATION OF MITOTIC CELL CYCLE,2
MAP3K8 (TPL2)-DEPENDENT MAPK1/3 ACTIVATION,2
ORC1 REMOVAL FROM CHROMATIN,2
DNA REPLICATION PRE-INITIATION,2
CDK-MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6,2
SWITCHING OF ORIGINS TO A POST-REPLICATIVE STATE,2
SYNTHESIS OF DNA,2
DNA REPLICATION,2
REGULATION OF EXPRESSION OF SLITS AND ROBOS,2
IRAK1 RECRUITS IKK COMPLEX,2
IRAK1 RECRUITS IKK COMPLEX UPON TLR7/8 OR 9 STIMULATION,2
TRANSFERRIN ENDOCYTOSIS AND RECYCLING,2
IRON METABOLISM IN PLACENTA,2
PLATELET ADHESION TO EXPOSED COLLAGEN,2
CELL-TYPE DEPENDENT SELECTIVITY OF CCK2R SIGNALING,2
GOLGI ASSOCIATED VESICLE BIOGENESIS,2
CREATION OF C4 AND C2 ACTIVATORS,1
CLASSICAL ANTIBODY-MEDIATED COMPLEMENT ACTIVATION,1
RHO GTPASES REGULATE CFTR TRAFFICKING,1
ALPHA-DEFENSINS,1
NEF MEDIATED CD4 DOWN-REGULATION,1
SIRT1 NEGATIVELY REGULATES RRNA EXPRESSION,1
MELATONIN METABOLISM AND EFFECTS,1
R-HSA-9635465,1
R-HSA-9652169,1
R-HSA-9652817,1
FORMATION OF APOPTOSOME,1
CYTOCHROME C-MEDIATED APOPTOTIC RESPONSE,1
PHOSPHO-PLA2 PATHWAY,1
GOLGI CISTERNAE PERICENTRIOLAR STACK REORGANIZATION,1
ERKS ARE INACTIVATED,1
RECYCLING PATHWAY OF L1,1
RSK ACTIVATION,1
THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS (PARS),1
RHO GTPASES ACTIVATE WASPS AND WAVES,1
NEGATIVE FEEDBACK REGULATION OF MAPK PATHWAY,1
MITOTIC PROPHASE,1
REGULATION OF THE APOPTOSOME ACTIVITY,1
ESTROGEN-STIMULATED SIGNALING THROUGH PRKCZ,1
ENDOTHELIN PATHWAYS,1
PDGF PATHWAY,1
SEROTONIN RECEPTOR 2 AND ELK-SRF-GATA4 SIGNALING,1
VASOPRESSIN-LIKE RECEPTORS,1
ION TRANSPORT BY P-TYPE ATPASES,1
TERMINAL PATHWAY OF COMPLEMENT,1
ROS AND RNS PRODUCTION IN PHAGOCYTES,1
EVENTS ASSOCIATED WITH PHAGOCYTOLYTIC ACTIVITY OF PMN CELLS,1
BENZENE METABOLISM,1
COPII-MEDIATED VESICLE TRANSPORT,1
CARGO CONCENTRATION IN THE ER,1
P38MAPK EVENTS,1
ACTIVATION OF PPARGC1A (PGC-1ALPHA) BY PHOSPHORYLATION,1
SIGNAL AMPLIFICATION,1
ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 1,1
STRIATED MUSCLE CONTRACTION,1
MUSCLE CONTRACTION,1
STRIATED MUSCLE CONTRACTION PATHWAY,1
R-HSA-9675143,1
RETINOID CYCLE DISEASE EVENTS,1
DISEASES ASSOCIATED WITH VISUAL TRANSDUCTION,1
METABOLISM OF FAT-SOLUBLE VITAMINS,1
RETINOID METABOLISM AND TRANSPORT,1
PYRIMIDINE CATABOLISM,1
PURINE CATABOLISM,1
NUCLEOBASE CATABOLISM,1
PYRIMIDINE METABOLISM,1
ALTERNATIVE COMPLEMENT ACTIVATION,1
INITIATION OF NUCLEAR ENVELOPE REFORMATION,1
NUCLEAR ENVELOPE REASSEMBLY,1
EV RELEASE FROM CARDIAC CELLS AND THEIR FUNCTIONAL EFFECTS,1
ACTIVATION OF NOXA AND TRANSLOCATION TO MITOCHONDRIA,1
ACTIVATION OF PUMA AND TRANSLOCATION TO MITOCHONDRIA,1
FORMATION OF SENESCENCE-ASSOCIATED HETEROCHROMATIN FOCI (SAHF),1
TP53 REGULATES TRANSCRIPTION OF SEVERAL ADDITIONAL CELL DEATH GENES WHOSE SPECIFIC ROLES IN P53-DEPENDENT APOPTOSIS REMAIN UNCERTAIN,1
TP53 REGULATES TRANSCRIPTION OF ADDITIONAL CELL CYCLE GENES WHOSE EXACT ROLE IN THE P53 PATHWAY REMAIN UNCERTAIN,1
REGULATION OF TP53 EXPRESSION,1
PI5P REGULATES TP53 ACETYLATION,1
FLUOROPYRIMIDINE ACTIVITY,1
ULTRACONSERVED REGION 339 MODULATION OF TUMOR SUPPRESSOR MICRORNAS IN CANCER,1
VEGF LIGAND-RECEPTOR INTERACTIONS,1
VEGF BINDS TO VEGFR LEADING TO RECEPTOR DIMERIZATION,1
VEGFR2 MEDIATED CELL PROLIFERATION,1
ROBO4 AND VEGF SIGNALING PATHWAYS CROSSTALK,1
TRANSLOCATION OF SLC2A4 (GLUT4) TO THE PLASMA MEMBRANE,1
"TETRAHYDROBIOPTERIN (BH4) SYNTHESIS, RECYCLING, SALVAGE AND REGULATION",1
METABOLISM OF NITRIC OXIDE: ENOS ACTIVATION AND REGULATION,1
ENOS ACTIVATION,1
AKT-MEDIATED INACTIVATION OF FOXO1A,1
BUTYRATE RESPONSE FACTOR 1 (BRF1) BINDS AND DESTABILIZES MRNA,1
RAB GEFS EXCHANGE GTP FOR GDP ON RABS,1
RUNX2 REGULATES GENES INVOLVED IN CELL MIGRATION,1
METABOLISM OF COFACTORS,1
RAB REGULATION OF TRAFFICKING,1
REGULATION OF LOCALIZATION OF FOXO TRANSCRIPTION FACTORS,1
LIPID METABOLISM PATHWAY,1
EGFR TRANSACTIVATION BY GASTRIN,1
INFLUENZA VIRUS INDUCED APOPTOSIS,1
MOLECULES ASSOCIATED WITH ELASTIC FIBRES,1
SYNDECAN INTERACTIONS,1
LOSS OF FUNCTION OF TGFBR2 IN CANCER,1
TGFBR2 MSI FRAMESHIFT MUTANTS IN CANCER,1
TGFBR2 KINASE DOMAIN MUTANTS IN CANCER,1
TGFBR1 LBD MUTANTS IN CANCER,1
INSULIN PROCESSING,1
COPI-MEDIATED ANTEROGRADE TRANSPORT,1
IRS ACTIVATION,1
INSULIN RECEPTOR RECYCLING,1
GLUCOSE HOMEOSTASIS,1
"POU5F1 (OCT4), SOX2, NANOG ACTIVATE GENES RELATED TO PROLIFERATION",1
TRANSCRIPTIONAL REGULATION OF PLURIPOTENT STEM CELLS,1
MET ACTIVATES STAT3,1
INTERLEUKIN-23 SIGNALING,1
CELL DIFFERENTIATION - INDEX EXPANDED,1
CELL DIFFERENTIATION - INDEX,1
HDAC6 INTERACTIONS,1
SEROTONIN RECEPTOR 2 AND STAT3 SIGNALING,1
R-HSA-9664420,1
R-HSA-9673324,1
ACTIVATION OF BIM AND TRANSLOCATION TO MITOCHONDRIA ,1
ACTIVATION OF BMF AND TRANSLOCATION TO MITOCHONDRIA,1
NRAGE SIGNALS DEATH THROUGH JNK,1
INTERLEUKIN-38 SIGNALING,1
OSTEOCLAST SIGNALING,1
ETHANOL METABOLISM RESULTING IN PRODUCTION OF ROS BY CYP2E1,1
LEPTIN AND ADIPONECTIN,1
ANDROGEN BIOSYNTHESIS,1
GLUCOCORTICOID BIOSYNTHESIS,1
METABOLISM OF STEROID HORMONES,1
G-PROTEIN ACTIVATION,1
PEPTIDE HORMONE BIOSYNTHESIS,1
METABOLIC DISORDERS OF BIOLOGICAL OXIDATION ENZYMES,1
DEFECTIVE ACTH CAUSES OBESITY AND PRO-OPIOMELANOCORTININ DEFICIENCY (POMCD),1
FASL/ CD95L SIGNALING,1
ERYTHROCYTES TAKE UP CARBON DIOXIDE AND RELEASE OXYGEN,1
ERYTHROCYTES TAKE UP OXYGEN AND RELEASE CARBON DIOXIDE,1
REVERSIBLE HYDRATION OF CARBON DIOXIDE,1
O2/CO2 EXCHANGE IN ERYTHROCYTES,1
RECYCLING OF BILE ACIDS AND SALTS,1
"PLASMA LIPOPROTEIN ASSEMBLY, REMODELING, AND CLEARANCE",1
METABOLISM OF PORPHYRINS,1
HEME BIOSYNTHESIS,1
HEME DEGRADATION,1
BILE ACID AND BILE SALT METABOLISM,1
SCAVENGING OF HEME FROM PLASMA,1
"TRANSPORT OF VITAMINS, NUCLEOSIDES, AND RELATED MOLECULES",1
TRANSPORT OF ORGANIC ANIONS,1
PLASMA LIPOPROTEIN REMODELING,1
HDL REMODELING,1
REGULATED PROTEOLYSIS OF P75NTR,1
PKMTS METHYLATE HISTONE LYSINES,1
INOSITOL PHOSPHATE METABOLISM,1
SYNTHESIS OF IP3 AND IP4 IN THE CYTOSOL,1
PTEN LOSS OF FUNCTION IN CANCER,1
REGULATION OF PTEN MRNA TRANSLATION,1
RUNX1 REGULATES ESTROGEN RECEPTOR MEDIATED TRANSCRIPTION,1
MET ACTIVATES RAP1 AND RAC1,1
MET RECEPTOR RECYCLING,1
MET PROMOTES CELL MOTILITY,1
SEROTONIN AND ANXIETY-RELATED EVENTS,1
PLC-GAMMA1 SIGNALLING,1
RETROGRADE NEUROTROPHIN SIGNALLING,1
ACTIVATION OF TRKA RECEPTORS,1
NGF-INDEPENDANT TRKA ACTIVATION,1
TRKA ACTIVATION BY NGF,1
SIGNALLING TO P38 VIA RIT AND RIN,1
MAPK6-MAPK4 SIGNALING,1
GLYCOSAMINOGLYCAN METABOLISM,1
HYALURONAN METABOLISM,1
HYALURONAN UPTAKE AND DEGRADATION,1
R-HSA-9639288,1
MTORC1-MEDIATED SIGNALLING,1
ENERGY DEPENDENT REGULATION OF MTOR BY LKB1-AMPK,1
DNA DAMAGE-TELOMERE STRESS INDUCED SENESCENCE,1
MIR-517 RELATIONSHIP WITH ARCN1 AND USP1,1
ONE CARBON METABOLISM AND RELATED PATHWAYS,1
MYD88 DEFICIENCY (TLR5),1
IRAK4 DEFICIENCY (TLR5),1
NETRIN MEDIATED REPULSION SIGNALS,1
FRS-MEDIATED FGFR2 SIGNALING,1
FRS-MEDIATED FGFR3 SIGNALING,1
FRS-MEDIATED FGFR4 SIGNALING,1
MET ACTIVATES PTPN11,1
ACTIVATED NTRK2 SIGNALS THROUGH FRS2 AND FRS3,1
PILOCYTIC ASTROCYTOMA,1
R-HSA-9669914,1
R-HSA-9669917,1
R-HSA-9669921,1
R-HSA-9669924,1
R-HSA-9669926,1
R-HSA-9669929,1
R-HSA-9669933,1
R-HSA-9669934,1
R-HSA-9669935,1
R-HSA-9669936,1
R-HSA-9669937,1
R-HSA-9680187,1
METABOLISM OF AMINE-DERIVED HORMONES,1
CATECHOLAMINE BIOSYNTHESIS,1
NICOTINE ACTIVITY ON DOPAMINERGIC NEURONS,1
BIOGENIC AMINE SYNTHESIS,1
TRANSFER OF LPS FROM LBP CARRIER TO CD14,1
MACROPHAGE MARKERS,1
TLR3 DEFICIENCY - HSE,1
UNC93B1 DEFICIENCY - HSE,1
TICAM1 DEFICIENCY - HSE,1
TRAF3 DEFICIENCY - HSE,1
TLR3-MEDIATED TICAM1-DEPENDENT PROGRAMMED CELL DEATH,1
BMP2-WNT4-FOXO1 PATHWAY IN HUMAN PRIMARY ENDOMETRIAL STROMAL CELL DIFFERENTIATION,1
HORMONAL CONTROL OF PUBERTAL GROWTH SPURT,1
SENSING OF DNA DOUBLE STRAND BREAKS,1
HOMOLOGOUS RECOMBINATION,1
DDX1 AS A REGULATORY COMPONENT OF THE DROSHA MICROPROCESSOR,1
DNA IR-DOUBLE STRAND BREAKS (DSBS) AND CELLULAR RESPONSE VIA ATM,1
DNA IR-DAMAGE AND CELLULAR RESPONSE VIA ATR,1
CLASS B/2 (SECRETIN FAMILY RECEPTORS),1
VITAMIN D METABOLISM,1
OSTEOBLAST SIGNALING,1
ACTIVATION OF SMO,1
R-HSA-9645722,1
R-HSA-9645723,1
R-HSA-9646303,1
R-HSA-9646304,1
R-HSA-9675132,1
DISEASES OF CELLULAR SENESCENCE,1
EVASION OF ONCOGENE INDUCED SENESCENCE DUE TO P16INK4A DEFECTS,1
EVASION OF ONCOGENE INDUCED SENESCENCE DUE TO DEFECTIVE P16INK4A BINDING TO CDK4,1
EVASION OF ONCOGENE INDUCED SENESCENCE DUE TO DEFECTIVE P16INK4A BINDING TO CDK4 AND CDK6,1
EVASION OF OXIDATIVE STRESS INDUCED SENESCENCE DUE TO P16INK4A DEFECTS,1
EVASION OF OXIDATIVE STRESS INDUCED SENESCENCE DUE TO DEFECTIVE P16INK4A BINDING TO CDK4,1
EVASION OF OXIDATIVE STRESS INDUCED SENESCENCE DUE TO DEFECTIVE P16INK4A BINDING TO CDK4 AND CDK6,1
TUMOR SUPPRESSOR ACTIVITY OF SMARCB1,1
HATS ACETYLATE HISTONES,1
SUMOYLATION OF TRANSCRIPTION COFACTORS,1
ACTIVATION OF ANTERIOR HOX GENES IN HINDBRAIN DEVELOPMENT DURING EARLY EMBRYOGENESIS,1
ACTIVATION OF HOX GENES DURING DIFFERENTIATION,1
ACTIVATION OF THE TFAP2 (AP-2) FAMILY OF TRANSCRIPTION FACTORS,1
FOXO-MEDIATED TRANSCRIPTION OF CELL DEATH GENES,1
MODEL FOR REGULATION OF MSMP EXPRESSION IN CANCER CELLS AND ITS PROANGIOGENIC ROLE IN OVARIAN TUMORS,1
MEIOTIC SYNAPSIS,1
TRANSCRIPTIONAL REGULATION BY E2F6,1
APOPTOSIS INDUCED DNA FRAGMENTATION,1
TNFS BIND THEIR PHYSIOLOGICAL RECEPTORS,1
NEF MEDIATED DOWNREGULATION OF CD28 CELL SURFACE EXPRESSION,1
RELEASE OF APOPTOTIC FACTORS FROM THE MITOCHONDRIA,1
"ACTIVATION, TRANSLOCATION AND OLIGOMERIZATION OF BAX",1
NTRK3 AS A DEPENDENCE RECEPTOR,1
MITOCHONDRIAL FATTY ACID SYNTHESIS AND RESPIRATION,1
ACTIVATION OF THE PHOTOTRANSDUCTION CASCADE,1
THE PHOTOTRANSDUCTION CASCADE,1
"INACTIVATION, RECOVERY AND REGULATION OF THE PHOTOTRANSDUCTION CASCADE",1
OPSINS,1
CILIUM ASSEMBLY,1
VXPX CARGO-TARGETING TO CILIUM,1
CARGO TRAFFICKING TO THE PERICILIARY MEMBRANE,1
R-HSA-9635644,1
CROSSLINKING OF COLLAGEN FIBRILS,1
CASPASE-MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS,1
ACTIVATION OF AMPK DOWNSTREAM OF NMDARS,1
OTHER SEMAPHORIN INTERACTIONS,1
LIPID STORAGE AND PERILIPINS IN SKELETAL MUSCLE,1
NICOTINATE METABOLISM,1
METABOLISM OF WATER-SOLUBLE VITAMINS AND COFACTORS,1
NICOTINAMIDE SALVAGING,1
ARACHIDONIC ACID METABOLISM,1
SYNTHESIS OF 15-EICOSATETRAENOIC ACID DERIVATIVES,1
SYNTHESIS OF PROSTAGLANDINS (PG) AND THROMBOXANES (TX),1
FATTY ACID METABOLISM,1
BIOSYNTHESIS OF DHA-DERIVED SPMS,1
BIOSYNTHESIS OF SPECIALIZED PRORESOLVING MEDIATORS (SPMS),1
BIOSYNTHESIS OF EPA-DERIVED SPMS,1
BIOSYNTHESIS OF DPA-DERIVED SPMS,1
BIOSYNTHESIS OF DPAN-3 SPMS,1
BIOSYNTHESIS OF ELECTROPHILIC Î©-3 PUFA OXO-DERIVATIVES,1
EICOSANOID SYNTHESIS,1
RMTS METHYLATE HISTONE ARGININES,1
FCERI MEDIATED CA+2 MOBILIZATION,1
MITOCHONDRIAL PROTEIN IMPORT,1
CRISTAE FORMATION,1
COLLAGEN BIOSYNTHESIS AND MODIFYING ENZYMES,1
TRANSCRIPTIONAL CASCADE REGULATING ADIPOGENESIS,1
GLYCOLYSIS,1
GLUCONEOGENESIS,1
GLUCOSE METABOLISM,1
METABOLIC REPROGRAMMING IN COLON CANCER,1
GLYCOLYSIS AND GLUCONEOGENESIS,1
AXONAL GROWTH INHIBITION (RHOA ACTIVATION),1
P75NTR REGULATES AXONOGENESIS,1
AXONAL GROWTH STIMULATION,1
SEMA4D IN SEMAPHORIN SIGNALING,1
G ALPHA (12/13) SIGNALLING EVENTS,1
SEMA4D MEDIATED INHIBITION OF CELL ATTACHMENT AND MIGRATION,1
SEMA4D INDUCED CELL MIGRATION AND GROWTH-CONE COLLAPSE,1
RHO GTPASES ACTIVATE CIT,1
RHO GTPASES ACTIVATE KTN1,1
RHO GTPASES ACTIVATE ROCKS,1
RHO GTPASES ACTIVATE RHOTEKIN AND RHOPHILINS,1
SLIT2:ROBO1 INCREASES RHOA ACTIVITY,1
G PROTEIN SIGNALING PATHWAYS,1
HYPOTHETICAL CRANIOFACIAL DEVELOPMENT PATHWAY,1
TYPE III INTERFERON SIGNALING,1
ATF6 (ATF6-ALPHA) ACTIVATES CHAPERONES,1
IRE1ALPHA ACTIVATES CHAPERONES,1
ATF6 (ATF6-ALPHA) ACTIVATES CHAPERONE GENES,1
PHOTODYNAMIC THERAPY-INDUCED UNFOLDED PROTEIN RESPONSE,1
STAT6-MEDIATED INDUCTION OF CHEMOKINES,1
IRF3 MEDIATED ACTIVATION OF TYPE 1 IFN,1
IRF3-MEDIATED INDUCTION OF TYPE I IFN,1
INTERLEUKIN-1 INDUCED ACTIVATION OF NF-KAPPA-B,1
"TRANSPORT OF BILE SALTS AND ORGANIC ACIDS, METAL IONS AND AMINE COMPOUNDS",1
METAL ION SLC TRANSPORTERS,1
DEFECTIVE SLC40A1 CAUSES HEMOCHROMATOSIS 4 (HFE4) (MACROPHAGES),1
DEFECTIVE CP CAUSES ACERULOPLASMINEMIA (ACERULOP),1
SLC TRANSPORTER DISORDERS,1
PKA-MEDIATED PHOSPHORYLATION OF CREB,1
CAMK IV-MEDIATED PHOSPHORYLATION OF CREB,1
CREB PHOSPHORYLATION,1
NOTCH2 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION,1
CREB1 PHOSPHORYLATION THROUGH THE ACTIVATION OF ADENYLATE CYCLASE,1
CREB1 PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII/CAMKK/CAMKIV CASCASDE,1
FOLATE-ALCOHOL AND CANCER PATHWAY HYPOTHESES,1
MITOCHONDRIAL GENE EXPRESSION,1
PHOSPHODIESTERASES IN NEURONAL FUNCTION,1
DISPLACEMENT OF DNA GLYCOSYLASE BY APEX1,1
POLB-DEPENDENT LONG PATCH BASE EXCISION REPAIR,1
RESOLUTION OF AP SITES VIA THE MULTIPLE-NUCLEOTIDE PATCH REPLACEMENT PATHWAY,1
RESOLUTION OF AP SITES VIA THE SINGLE-NUCLEOTIDE REPLACEMENT PATHWAY,1
PCNA-DEPENDENT LONG PATCH BASE EXCISION REPAIR,1
BASE EXCISION REPAIR,1
ABASIC SUGAR-PHOSPHATE REMOVAL VIA THE SINGLE-NUCLEOTIDE REPLACEMENT PATHWAY,1
RESOLUTION OF ABASIC SITES (AP SITES),1
RUNX1 REGULATES TRANSCRIPTION OF GENES INVOLVED IN DIFFERENTIATION OF KERATINOCYTES,1
SEROTONIN TRANSPORTER ACTIVITY,1
ERYTHROPOIETIN ACTIVATES PHOSPHOLIPASE C GAMMA (PLCG),1
ERYTHROPOIETIN ACTIVATES RAS,1
PURINE SALVAGE,1
NUCLEOTIDE SALVAGE,1
PURINE METABOLISM,1
ENDOSOMAL/VACUOLAR PATHWAY,1
TRAIL  SIGNALING,1
PREIMPLANTATION EMBRYO,1
BETA-CATENIN PHOSPHORYLATION CASCADE,1
APOPTOTIC CLEAVAGE OF CELL ADHESION  PROTEINS,1
CA2+ PATHWAY,1
DISASSEMBLY OF THE DESTRUCTION COMPLEX AND RECRUITMENT OF AXIN TO THE MEMBRANE,1
SIGNALING BY WNT IN CANCER,1
PHOSPHORYLATION SITE MUTANTS OF CTNNB1 ARE NOT TARGETED TO THE PROTEASOME BY THE DESTRUCTION COMPLEX,1
MISSPLICED GSK3BETA MUTANTS STABILIZE BETA-CATENIN,1
S33 MUTANTS OF BETA-CATENIN AREN'T PHOSPHORYLATED,1
S37 MUTANTS OF BETA-CATENIN AREN'T PHOSPHORYLATED,1
S45 MUTANTS OF BETA-CATENIN AREN'T PHOSPHORYLATED,1
T41 MUTANTS OF BETA-CATENIN AREN'T PHOSPHORYLATED,1
RHO GTPASES ACTIVATE IQGAPS,1
ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY,1
REGULATION OF WNT-B-CATENIN SIGNALING BY SMALL MOLECULE COMPOUNDS,1
XENOBIOTICS,1
ARYL HYDROCARBON RECEPTOR SIGNALLING,1
SIGNALING BY NODAL,1
SIGNALING BY ACTIVIN,1
LOSS OF FUNCTION OF SMAD4 IN CANCER,1
SMAD4 MH2 DOMAIN MUTANTS IN CANCER,1
SMAD2/3 MH2 DOMAIN MUTANTS IN CANCER,1
RUNX3 REGULATES BCL2L11 (BIM) TRANSCRIPTION,1
CROSS-PRESENTATION OF PARTICULATE EXOGENOUS ANTIGENS (PHAGOSOMES),1
SCAVENGING BY CLASS B RECEPTORS,1
FREE FATTY ACIDS REGULATE INSULIN SECRETION,1
INTRACELLULAR METABOLISM OF FATTY ACIDS REGULATES INSULIN SECRETION,1
TYROSINE CATABOLISM,1
PHENYLALANINE AND TYROSINE METABOLISM,1
METHIONINE DE NOVO AND SALVAGE PATHWAY,1
R-HSA-9645460,1
R-HSA-9648002,1
R-HSA-9683683,1
R-HSA-9683701,1
TRANSLESION SYNTHESIS BY REV1,1
RECOGNITION OF DNA DAMAGE BY PCNA-CONTAINING REPLICATION COMPLEX,1
TRANSLESION SYNTHESIS BY POLH,1
DOWNREGULATION OF ERBB4 SIGNALING,1
BUDDING AND MATURATION OF HIV VIRION,1
LATE PHASE OF HIV LIFE CYCLE,1
REGULATION OF APOPTOSIS,1
APC/C:CDC20 MEDIATED DEGRADATION OF CYCLIN B,1
AUTODEGRADATION OF CDH1 BY CDH1:APC/C,1
SCF-BETA-TRCP MEDIATED DEGRADATION OF EMI1,1
APC/C:CDC20 MEDIATED DEGRADATION OF SECURIN,1
APC/C:CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC/C:CDH1 TARGETED PROTEINS IN LATE MITOSIS/EARLY G1,1
CDC20:PHOSPHO-APC/C MEDIATED DEGRADATION OF CYCLIN A,1
MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS,1
"SYNTHESIS AND PROCESSING OF GAG, GAGPOL POLYPROTEINS",1
ASSEMBLY OF THE HIV VIRION,1
APC/C:CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS,1
ACTIVATION OF APC/C AND APC/C:CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS,1
APC-CDC20 MEDIATED DEGRADATION OF NEK2A,1
APC:CDC20 MEDIATED DEGRADATION OF CELL CYCLE PROTEINS PRIOR TO SATISFATION OF THE CELL CYCLE CHECKPOINT,1
VIF-MEDIATED DEGRADATION OF APOBEC3G,1
REGULATION OF ACTIVATED PAK-2P34 BY PROTEASOME MEDIATED DEGRADATION,1
SEPARATION OF SISTER CHROMATIDS,1
REGULATION OF PLK1 ACTIVITY AT G2/M TRANSITION,1
STIMULI-SENSING CHANNELS,1
NOTCH2 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS,1
GLYCOGEN STORAGE DISEASES,1
GLYCOGEN SYNTHESIS,1
MYOCLONIC EPILEPSY OF LAFORA,1
ASYMMETRIC LOCALIZATION OF PCP PROTEINS,1
DEGRADATION OF AXIN,1
DEGRADATION OF DVL,1
REGULATION OF FZD BY UBIQUITINATION,1
N-GLYCAN TRIMMING IN THE ER AND CALNEXIN/CALRETICULIN CYCLE,1
HEDGEHOG LIGAND BIOGENESIS,1
HH MUTANTS THAT DON'T UNDERGO AUTOCATALYTIC PROCESSING ARE DEGRADED BY ERAD,1
HH MUTANTS ABROGATE LIGAND SECRETION,1
DEGRADATION OF GLI1 BY THE PROTEASOME,1
DEGRADATION OF GLI2 BY THE PROTEASOME,1
GLI3 IS PROCESSED TO GLI3R BY THE PROTEASOME,1
HEDGEHOG 'OFF' STATE,1
TRANSLESION SYNTHESIS BY POLK,1
TRANSLESION SYNTHESIS BY POLI,1
REGULATION OF RAS BY GAPS,1
DISEASES OF CARBOHYDRATE METABOLISM,1
NIK-->NONCANONICAL NF-KB SIGNALING,1
JOSEPHIN DOMAIN DUBS,1
DNA DAMAGE RECOGNITION IN GG-NER,1
FORMATION OF INCISION COMPLEX IN GG-NER,1
GAP-FILLING DNA REPAIR SYNTHESIS AND LIGATION IN GG-NER,1
NUCLEOTIDE EXCISION REPAIR,1
GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR (GG-NER),1
DUAL INCISION IN GG-NER,1
FORMATION OF TC-NER PRE-INCISION COMPLEX,1
TRANSCRIPTION-COUPLED NUCLEOTIDE EXCISION REPAIR (TC-NER),1
DUAL INCISION IN TC-NER,1
GAP-FILLING DNA REPAIR SYNTHESIS AND LIGATION IN TC-NER,1
FANCONI ANEMIA PATHWAY,1
CDT1 ASSOCIATION WITH THE CDC6:ORC:ORIGIN COMPLEX,1
ASSEMBLY OF THE PRE-REPLICATIVE COMPLEX,1
UBIQUITIN MEDIATED DEGRADATION OF PHOSPHORYLATED CDC25A,1
P53-INDEPENDENT DNA DAMAGE RESPONSE,1
P53-INDEPENDENT G1/S DNA DAMAGE CHECKPOINT,1
PROTEIN UBIQUITINATION,1
FBXL7 DOWN-REGULATES AURKA DURING MITOTIC ENTRY AND IN EARLY MITOSIS,1
SYNTHESIS OF ACTIVE UBIQUITIN: ROLES OF E1 AND E2 ENZYMES,1
E3 UBIQUITIN LIGASES UBIQUITINATE TARGET PROTEINS,1
RUNX1 REGULATES TRANSCRIPTION OF GENES INVOLVED IN DIFFERENTIATION OF HSCS,1
GLYCOGEN METABOLISM,1
ER QUALITY CONTROL COMPARTMENT (ERQC),1
CALNEXIN/CALRETICULIN CYCLE,1
IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX,1
SUMOYLATION OF UBIQUITINYLATION PROTEINS,1
TRAFFICKING OF AMPA RECEPTORS,1
"GLUTAMATE BINDING, ACTIVATION OF AMPA RECEPTORS AND SYNAPTIC PLASTICITY",1
R-HSA-9633012,1
L13A-MEDIATED TRANSLATIONAL SILENCING OF CERULOPLASMIN EXPRESSION,1
EUKARYOTIC TRANSLATION ELONGATION,1
PEPTIDE CHAIN ELONGATION,1
INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION,1
SRP-DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,1
VIRAL MRNA TRANSLATION,1
SELENOAMINO ACID METABOLISM,1
SELENOCYSTEINE SYNTHESIS,1
MAJOR PATHWAY OF RRNA PROCESSING IN THE NUCLEOLUS AND CYTOSOL,1
RRNA PROCESSING,1
EUKARYOTIC TRANSLATION INITIATION,1
TRANSLATION INITIATION COMPLEX FORMATION,1
"ACTIVATION OF THE MRNA UPON BINDING OF THE CAP-BINDING COMPLEX AND EIFS, AND SUBSEQUENT BINDING TO 43S",1
FORMATION OF A POOL OF FREE 40S SUBUNITS,1
"FORMATION OF THE TERNARY COMPLEX, AND SUBSEQUENTLY, THE 43S COMPLEX",1
RIBOSOMAL SCANNING AND START CODON RECOGNITION,1
GTP HYDROLYSIS AND JOINING OF THE 60S RIBOSOMAL SUBUNIT,1
CAP-DEPENDENT TRANSLATION INITIATION,1
EUKARYOTIC TRANSLATION TERMINATION,1
TRANSLATION,1
RRNA PROCESSING IN THE NUCLEUS AND CYTOSOL,1
NONSENSE-MEDIATED DECAY (NMD),1
NONSENSE MEDIATED DECAY (NMD) INDEPENDENT OF THE EXON JUNCTION COMPLEX (EJC),1
NONSENSE MEDIATED DECAY (NMD) ENHANCED BY THE EXON JUNCTION COMPLEX (EJC),1
CYTOPLASMIC RIBOSOMAL PROTEINS,1
SHC-RELATED EVENTS TRIGGERED BY IGF1R,1
GENES TARGETED BY MIRNAS IN ADIPOCYTES,1
METAL SEQUESTRATION BY ANTIMICROBIAL PROTEINS,1
R-HSA-9675151,1
TRANSCRIPTION OF E2F TARGETS UNDER NEGATIVE CONTROL BY P107 (RBL1) AND P130 (RBL2) IN COMPLEX WITH HDAC1,1
P75NTR NEGATIVELY REGULATES CELL CYCLE VIA SC1,1
HDACS DEACETYLATE HISTONES,1
ERCC6 (CSB) AND EHMT2 (G9A) POSITIVELY REGULATE RRNA EXPRESSION,1
NORC NEGATIVELY REGULATES RRNA EXPRESSION,1
SUMOYLATION OF CHROMATIN ORGANIZATION PROTEINS,1
REPRESSION OF WNT TARGET GENES,1
POSITIVE EPIGENETIC REGULATION OF RRNA EXPRESSION,1
G1/S-SPECIFIC TRANSCRIPTION,1
RNA POLYMERASE I TRANSCRIPTION INITIATION,1
RNA POLYMERASE I PROMOTER CLEARANCE,1
RNA POLYMERASE I TRANSCRIPTION,1
RUNX1 REGULATES GENES INVOLVED IN MEGAKARYOCYTE DIFFERENTIATION AND PLATELET FUNCTION,1
LOSS OF FUNCTION OF MECP2 IN RETT SYNDROME,1
PERVASIVE DEVELOPMENTAL DISORDERS,1
LOSS OF MECP2 BINDING ABILITY TO 5MC-DNA,1
VALPROIC ACID PATHWAY,1
ETHANOL EFFECTS ON HISTONE MODIFICATIONS,1
NEF AND SIGNAL TRANSDUCTION,1
EPHRIN SIGNALING,1
SEMA3A PAK DEPENDENT AXON REPULSION,1
SEMA3A-PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION,1
CRMPS IN SEMA3A SIGNALING,1
DCC MEDIATED ATTRACTIVE SIGNALING,1
REELIN SIGNALLING PATHWAY,1
ACTIVATED NTRK2 SIGNALS THROUGH FYN,1
NTRK2 ACTIVATES RAC1,1
SMALL LIGAND GPCRS,1
GASTRIC ACID PRODUCTION,1
R-HSA-9651496,1
R-HSA-9662001,1
R-HSA-9671793,1
R-HSA-9672391,1
R-HSA-9672393,1
INTRINSIC PATHWAY OF FIBRIN CLOT FORMATION,1
FORMATION OF FIBRIN CLOT (CLOTTING CASCADE),1
GRB2:SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTEGRINS ,1
NEUROTRANSMITTER RELEASE CYCLE,1
CHL1 INTERACTIONS,1
MRNA SPLICING - MAJOR PATHWAY,1
MRNA SPLICING,1
PROCESSING OF CAPPED INTRON-CONTAINING PRE-MRNA,1
PROTEIN METHYLATION,1
"GABA SYNTHESIS, RELEASE, REUPTAKE AND DEGRADATION",1
LIPOPHAGY,1
EXERCISE-INDUCED CIRCADIAN REGULATION,1
RUNX1 REGULATES TRANSCRIPTION OF GENES INVOLVED IN INTERLEUKIN SIGNALING,1
RAF ACTIVATION,1
MITOCHONDRIAL CALCIUM ION TRANSPORT,1
PROCESSING OF SMDT1,1
PRE-NOTCH PROCESSING IN THE ENDOPLASMIC RETICULUM,1
PRE-NOTCH PROCESSING IN GOLGI,1
FBXW7 MUTANTS AND NOTCH1 IN CANCER,1
LOSS OF FUNCTION OF FBXW7 IN CANCER AND NOTCH1 SIGNALING,1
SIGNALING BY NOTCH1 T(7;9)(NOTCH1:M1580_K2555) TRANSLOCATION MUTANT,1
CONSTITUTIVE SIGNALING BY NOTCH1 T(7;9)(NOTCH1:M1580_K2555) TRANSLOCATION MUTANT,1
DISEASES OF GLYCOSYLATION,1
DISEASES ASSOCIATED WITH O-GLYCOSYLATION OF PROTEINS,1
DEFECTIVE LFNG CAUSES SCDO3,1
GASTRIC CANCER NETWORK 1,1
GENE REGULATORY NETWORK MODELLING SOMITOGENESIS,1
CANONICAL AND NON-CANONICAL NOTCH SIGNALING,1
SIGNALING BY FGFR1 AMPLIFICATION MUTANTS,1
SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1,1
FGFR1 LIGAND BINDING AND ACTIVATION,1
FGFR1B LIGAND BINDING AND ACTIVATION,1
FGFR1C LIGAND BINDING AND ACTIVATION,1
FGFR1C AND KLOTHO LIGAND BINDING AND ACTIVATION,1
PHOSPHOLIPASE C-MEDIATED CASCADE: FGFR1,1
SHC-MEDIATED CASCADE:FGFR1,1
SIGNALING BY PLASMA MEMBRANE FGFR1 FUSIONS,1
NS1 MEDIATED EFFECTS ON HOST PATHWAYS,1
INHIBITION OF PKR,1
TRANSLATION FACTORS,1
IKBKB DEFICIENCY CAUSES SCID,1
IKBKG DEFICIENCY CAUSES ANHIDROTIC ECTODERMAL DYSPLASIA WITH IMMUNODEFICIENCY (EDA-ID) (VIA TLR),1
NCAM1 INTERACTIONS,1
TELOMERE MAINTENANCE,1
TELOMERE EXTENSION BY TELOMERASE,1
ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS,1
EXTENSION OF TELOMERES,1
G2 PHASE,1
ACTIVATION OF THE PRE-REPLICATIVE COMPLEX,1
PHOSPHORYLATION OF PROTEINS INVOLVED IN G1/S TRANSITION BY ACTIVE CYCLIN E:CDK2 COMPLEXES,1
CYCLIN A/B1/B2 ASSOCIATED EVENTS DURING G2/M TRANSITION,1
CHROMOSOME MAINTENANCE,1
ID SIGNALING PATHWAY,1
THE NLRP1 INFLAMMASOME,1
INFLUENZA A VIRUS INFECTION,1
NANOPARTICLE TRIGGERED AUTOPHAGIC CELL DEATH,1
